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In the United States alone, cardiovascular disease kills nearly one million people each 
year.  The inflammatory disease atherosclerosis has been implicated in more than three-
quarters of these deaths.  Despite the global nature of most risk factors, atherosclerosis 
has been identified as a focal disease occurring in defined regions of the vasculature.  
Plaques have been shown to localize at bifurcations or curves in the arterial tree where 
disturbed blood flow patterns and low, oscillatory shear stress (OS) exist.  In contrast, 
straight arteries exposed to high velocity, unidirectional laminar shear stress (LS) remain 
plaque free and “atheroprotected.”  In order to address the hemodynamic components of 
atherosclerosis development, recent work has focused on the mechanosensitive 
endothelium to establish new pathological mechanisms.   
 
Endothelial cells (EC) exposed to oscillatory shear stress experience oxidative stress as 
a signature of atherosclerosis.  Conversely, unidirectional laminar shear stress reduces 
reactive oxygen species (ROS) levels and subsequent inflammatory responses.  
Previous work by our group found that fluid flow stimulates these important functional 
changes through gene and protein expression regulation.  In the following study, we 
proposed that mechanosensitive antioxidants play a considerable role in laminar shear-
dependent redox balance and atheroprotection.  
 
Recently, a new group of ubiquitous antioxidant proteins has been acknowledged in 
yeast, plant and animal cells species.  The peroxiredoxins (PRX) are thiol specific-, non-
selenium containing enzymes that use redox-active cysteines to reduce peroxides and 
eliminate peroxynitrite.  However, they have yet to be investigated in response to shear 
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stress.  As such, the overall objective of this dissertation was to study the effects 
of atherogenic and atheroprotective fluid flow profiles on the mammalian 
antioxidants peroxiredoxins, and to identify mechanosensitive family members 
playing a role in redox regulation.  By understanding how peroxiredoxins are 
regulated and what roles they play physiologically, we will have better insight into 
endothelial cell (EC) biology and redox-sensitive mechanisms of vascular diseases.  The 
central hypothesis of this project was that unidirectional laminar shear stress 
(LS), compared to disturbed oscillatory shear stress (OS), promotes increased 
expression of peroxiredoxins (PRX) via transcriptional regulation, which in turn 
influences the balance of reactive oxygen species in endothelial cells.  This 
hypothesis was tested according to three specific aims using cellular, molecular, and 
biochemical studies of bovine aortic endothelial cells. 
 
We first explored the effects of shear stress on expression of mammalian peroxiredoxin 
family members.  Using an in vitro model, the cone-and-plate viscometer, we applied 
atheroprotective, high, unidirectional laminar shear stress or atherogenic, low, oscillatory 
shear stress to endothelial cells in culture.  Here, we were able to identify all six PRX 
family members in bovine aortic endothelial cells (BAEC).  Furthermore, through this 
work, we revealed for the first time that PRX are regulated by shear stress in endothelial 
cells.  When compared to OS and static culture, exposure to chronic LS upregulated 
PRX 1 levels intracellularly.  LS also increased expression of PRX 5 relative to static 
controls, but not OS.  Consistent with reports in other cell types, PRX exhibited broad 
subcellular localization in BAEC, with distribution in the cytoplasm, Golgi, mitochondria, 
and intermediate filaments.  However, these localization patterns did not appear to 
change in response to shear stress.  Taken together, our results suggest that distribution 
of PRX in specific subcellular environments may provide protection against local ROS 
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production and facilitate ROS-mediated signal transduction.  Simultaneously, 
widespread allocation of PRX might also be important for comprehensive management 
of the overall oxidative state of cells.  Moreover, upregulation of PRX 1 by LS may act to 
reduce ROS levels in EC and prevent atherogenic oxidative stress.  
 
To establish the functional importance of PRX 1 in shear stress-dependent redox 
balance, we next examined the role of PRX 1 in LS-mediated hydrogen peroxide 
regulation.  Endothelial cells exposed to OS experience oxidative stress as a signature 
of atherosclerosis.  Conversely, chronic LS reduces ROS levels.  Here, we used Amplex 
Red assay as an independent method to measure ROS levels in BAEC.  Consistent with 
previous reports, OS increased and LS decreased catalase-inhibitable hydrogen 
peroxide.  Subsequently, we investigated whether PRX 1 was responsible for the 
decreased H2O2 levels in endothelial cells exposed to LS.  Specific siRNAs were used to 
knockdown either PRX 1 or PRX 5 protein levels.  Using isoform-specific PRX 
antibodies, we found that these siRNAs had no significant effect on other PRX, 
indicating that they exclusively targeted PRX 1 or 5, respectively, amongst all PRX 
family members.  Depletion of PRX 1 using siRNA resulted in significantly higher ROS 
levels in BAEC exposed to LS, OS, and static conditions, while PRX 5 depletion did not.  
Altogether, these results indicate that chronic exposure to LS upregulates PRX 1 
expression in order to keep ROS levels low in endothelial cells.  
 
To identify the pathway by which atheroprotective laminar shear stress stimulates PRX 1 
protein production, we undertook additional gene expression and siRNA depletion 
studies.  Several reports have demonstrated that antioxidant genes are induced by 
laminar shear stress in endothelial cells.  In line with this, we discovered that LS 
upregulates Prdx1 gene in a time-dependent manner compared to OS or static culture.  
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However, this increase in expression was not due to shear stress-dependent 
stabilization of Prdx1 mRNA.  These findings lead us to believe that Prdx1 was likely 
regulated at the transcriptional level.  In addition, the antioxidant response element 
(ARE) has been shown to be conserved amongst several antioxidant genes, and studies 
showed it responds to chronic, steady laminar shear stress through its transcription 
factor Nrf2.  Our analysis of the bovine Prdx1 promoter revealed a Nrf2 binding site 
160bp upstream of the gene.  Furthermore, Nrf2 overexpression promoted basal PRX 1 
protein production, while Nrf2 depletion reduced Prdx1 mRNA following exposure to LS.  
Collectively, our work illustrates that laminar shear stress affects PRX 1 by inducing the 
Prdx1 gene, in part via the transcription factor Nrf2.  
 
In this dissertation, we have developed a comprehensive register of shear stress-
dependent peroxiredoxin behavior and discovered a novel mechanosensitive antioxidant 
that plays an important functional role in redox regulation of endothelial cell biology.  
This work illustrates how physiologically relevant fluid flow affects reactive oxygen 
species, through the unique expression of antioxidants, in particular Peroxiredoxin 1.  
Identifying factors that play an important role in shear stress-dependent oxidative stress 
could help provide localized therapies at the site of endothelial cell dysfunction.  Our 
findings are relevant to the inflammatory disease atherosclerosis, a major cause of 
cardiovascular disease.  By understanding how PRX1 is regulated and what role it plays 
in physiology, we can better understand vascular diseases and develop effective 
preventative therapeutic approaches.  
 





Cardiovascular disease (CVD) affects an estimated 80 million American adults (one in 
three) and has been the leading cause of mortality in the United States for more than a 
century.  The inflammatory vessel disease atherosclerosis has been implicated in nearly 
three-quarters of these CVD deaths1.  In an effort to develop effective treatments for this 
pervasive pathology, research is now focused on the mechanisms of atherogenesis.  
Growing evidence indicates that overproduction of reactive oxygen species contributes 
significantly to the pathogenesis of atherosclerosis.  This dissertation will address the 
protective and pathological effects of arterial hemodynamics with respect to reactive 
oxygen species regulation.  In particular, we will investigate the how fluid flow mediates 
oxidative stress in endothelial cells with a concentration on antioxidant gene and protein 
expression.       
 
Atherosclerosis 
Atherosclerosis is responsible for more than half of reported deaths in the industrialized 
world2.  It is an inflammatory disease of the large arteries and is characterized by the 
development of lipid-filled plaques that obstruct the vessel lumen.  Lesion enlargement 
has been shown to progress over the lifetime of an individual, with plaque formation 
beginning decades before clinical manifestation3.  The disease process begins as a 
protective physiological response-to-injury, whereby leukocytes and monocytes adhere 
to the endothelium as a result of insult to the vessel wall.  These insults correspond to a 
number of behavioral and physiological risk factors including hypercholesterolemia, 
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smoking, hypertension, diabetes, genetic alterations, elevated homocysteine 





Figure 1.1  Atherosclerosis is an inflammatory disease. Endothelium dysfunction (A) 
results in fatty streak formation (B), advanced plaque development (C), and rupture (D).  
Figure reprinted with permission4.  Copyright © 1999 Massachusetts Medical Society.   
 
Advanced atherosclerotic lesions result from a chronic inflammatory response and 
endothelial dysfunction due to continued and numerous insults (Figure 1.1).  Early 
features in the pathogenesis of atherosclerosis include endothelial cell expression of 
vascular cell adhesion molecule-1 (VCAM-1), intercellular adhesion molecule-1 (ICAM-
1), and E-selectin, followed by cell surface attachment of circulating monocytes6-8.  Upon 
adhesion, monocytes migrate through the endothelium, localize subendothelially, and 
differentiate into macrophages.  These macrophages take up oxidized LDL (ox LDL), 
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accumulate lipid, and subsequently become foam cells2, 5.  In conjunction with T-cells 
and smooth muscle cells, these foam cells form a fatty streak that represents the earliest 
recognizable lesion2.  Foam cells and the endothelium secrete cytokines, including tumor 
necrosis factor-α (TNF- α), platelet-derived growth factor (PDGF), and transforming 
growth factor-β (TGF-ß), that promote endothelial cell apoptosis and initiate migration 
and proliferation of smooth muscle cells into the sub-intimal layer5, 9.  A repetitive cycle of 
monocyte accumulation and smooth muscle cell proliferation results in an atherosclerotic 
plaque that occludes the vessel lumen severely and alters downstream blood flow4.   
 
Following plaque formation, metalloproteases, collagenases and elastases can induce 
degradation in an effort to remodel the vessel wall and open the occluded lumen.  
However, this action causes the lesion to weaken and become susceptible to rupture5.  
Myocardial infarction and stroke occur as a result of plaque erosion and subsequent 
thrombosis at, or downstream of, the rupture site.       
   
Atherosclerosis and Hemodynamics 
Despite the global nature of most atherosclerotic risk factors, atherosclerosis has been 
identified as a focal disease occurring in defined regions of the vasculature.  Plaques 
have been shown to localize at bifurcations or curves in the arterial tree.  As such, 
vessels including the carotid bifurcation, coronary vessels, aortic arch, and abdominal 
aorta are particularly prone to atheroma formation.  Studies by Caro et al. in 1969 and 
Zarins et al. in 1983 showed that these areas of the vasculature coincide with regions of 
disturbed, low velocity blood flow10-12.  In contrast, straight arteries exposed to high 
velocity, unidirectional laminar flow remain plaque free and “atheroprotected”11, 13.  This 
phenomenon suggests that blood flow, and the forces it imparts on vessels, directly 
influence cellular function and play a critical role in vascular wall physiology.  
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Hemodynamic Forces in the Vasculature 
As the heart beats, pushing blood through the vascular system, pulsatile pressure and 
flow are generated and act on the vessels via three forces14, 15.  These hemodynamic 
stresses (forces per unit area) include compressive stress, circumferential stress, and 
shear stress (Figure 1.2).  Compressive stress results from the hydrostatic pressure of 
blood acting normal to the vessel wall.  Circumferential stress is caused by changes in 
vessel diameter due to the pulsatility of blood flow.  And lastly, frictional wall shear stress 
acts tangentially as a result of blood flow over the vessel wall14.  Although orders of 
magnitude smaller than blood pressure, this frictional stress has been identified as the 
critical force mediating flow-dependent atherogenesis or atheroprotection.  Disturbed 
blood flow at vessel branches correlates to low, bidirectional shear stress, while 
unidirectional laminar flow results in high unidirectional shear stress10, 11, 15.   
 
 
Figure 1.2  Blood flow acts on the arterial wall via three hemodynamic forces.    
Figure reprinted with permission14.  Copyright © 1997 American Chemical Society and 
American Institute of Chemical Engineers. 
 
 
Fluid shear stress, τ, is defined as the force produced by a moving viscous fluid over a 
solid body constraining its motion16.  In the large arteries where atherosclerosis occurs, 
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vessel diameter is much larger than individual cells, and blood can be considered a 
Newtonian fluid.  Newtonian fluids are those that possess a linear relationship between 
stress and strain rate, and their flow is governed by the Navier-Stokes equations.  As 
such, blood shear stress is proportional to fluid viscosity, µ, and the shear rate or velocity 





= µτ  






µτ =  
where Q is the flow rate and D is the diameter of the vessel18. 
 
At the cellular level, the effects of blood shear stress have been correlated to the 
behavior of the exposed endothelium.  Comparison of en face tissue staining from 
atheroprone and atheroprotected regions of the mouse aorta shows distinct differences 
in endothelial cell morphology, as well as expression of factors such as NFκB, ICAM-1, 
and VCAM-119.  In order to investigate these in vivo findings in a simplified setting, 
several in vitro systems have been developed that expose cultured cells to defined shear 
stresses20.   
 
In Vitro Models of Shear Stress  
Devices such as the parallel plate flow chamber and cone-and-plate viscometer (shear 
apparatus) have allowed for controlled shear stress experiments on endothelial cells20-24.  
In the parallel plate system, cells are cultured on glass slides and positioned within a 
rectangular flow chamber.  A roller pump is used to circulate medium through the 
chamber to provide uniform levels of shear stress.  The dimensions of the chamber and 
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the pressure drop across it dictate the fluid flow rate and result in specific shear stress 
conditions17.   
 
























Figure 1.3  Schematic of the cone-and-plate shear stress system    
 
In the cone-and-plate shear system, a Teflon cone is used to generate shear stress.  
The cone is placed in a circular culture dish containing adherent endothelial cells and 
medium.  As illustrated in Figure 1.3, the angle of the cone is very small (<10).  Rotation 
of the cone forces the fluid between the cone and plate to flow azimuthally and produce 
a shear stress on the stationary endothelial cell monolayer16.  The Navier-Stokes 
equations can be used to accurately calculate the magnitude and direction of this shear 
stress and to determine the limits to which this system can produce laminar arterial flow 
profiles16.  When compared to the parallel plate system, the cone-and-plate shear 
apparatus exhibits several disadvantages and advantages.  For example, the low 
volume of media used in the cone-and-plate viscometer may permit secreted growth 
factors and cytokines to accumulate over time and produce non-physiological effects on 
cultured cells.  In addition, this system results in a gradient of shear stress, and cells at 
the center of the culture dish, near the cone apex, may experience lower shear stress 
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than those at the perimeter.  Alternatively, the cone-and-plate viscometer can expose a 
greater number of cells to shear stress when compared to the parallel plate system 
using small glass coverslips.  This is critical in RNA and protein analysis of cells.  The 
system can also be used to simulate reversal of flow by rotating the cone back and forth.  
Although secondary flow can occur at high rotational speeds, this is generally negligible 
to achieve physiologically relevant shear stresses25.  As a result the cone-and-plate 
viscometer can expose cultured endothelial cells to both “atheroprone” oscillatory shear 
stress (OS) and “atheroprotective” unidirectional laminar shear stress (LS).  
 
Shear Stress and Endothelial Cell Biology 
In vitro studies utilizing the previously described flow models have established shear 
stress-dependent changes in endothelial cells similar to those observed in vivo.  For 
examples, cells align and elongate in the direction of flow upon exposure to a threshold 
level of unidirectional laminar shear stress17, 26.  Conversely, when cultured in the 
presence of low and oscillatory shear stress or static conditions, endothelial cells exhibit 
a cobblestone morphology with random orientation and do not align22.  This cellular 
process of identifying different shear stress forces and converting them to physiological 
responses is called mechanotransduction14, 27, 28. 
 
As shown in Figure 1.4, several membrane components have been established as 
“mechanoreceptors” of shear stress including the glycocalyx, integrins, platelet 
endothelial cell adhesion molecule-1 (PECAM-1), vascular endothelial-cadherin, tyrosine 
kinase receptors, G proteins, primary cilium, and ion channels14, 27-30.  Located at the 
surface of endothelial cells, they are poised to directly sense and transduce force across 
the membrane to the interior of cells14, 27.  Mechanoreceptors can transmit their signals 
via the cytoskeleton through focal adhesions, cell-cell junctions, and the nuclear 
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membrane or via a biochemical cascade through the generation of second messengers 
and transcription factor activation27, 28.  In addition to previously described morphological 
changes, mechanotransduction of different shear stresses can also elicit other structural, 
metabolic, and gene regulatory modifications28.   
 
 
Figure 1.4  Mechanoreceptors in endothelial cells exposed to shear stress    
Figure reprinted with permission27.  Copyright © 2008 Lippincott, Williams & Wilkins. 
 
In general, unidirectional laminar shear stress promotes an atheroprotective endothelial 
phenotype, while low, oscillatory shear stress stimulates atherogenic responses27, 31, 32.  
Steady laminar shear stress promotes the release of several factors that promote 
endothelial cell survival and prevent coagulation, migration of leukocytes, and smooth 
muscle cell and endothelial cell proliferation32.  Vasoactive molecules, including nitric 
oxide (NO•) and prostacyclin, promote vessel dilation and increased blood flow15, 17, 32.  In 
contrast, low and oscillatory shear stress induces the expression of surface molecules, 
including VCAM-1 and ICAM-1, as well as cytokines such as bone morphogenic protein-
4 and monocyte chemoattractant protein-1 (MCP-1) that promote monocyte adhesion17, 
21, 32.  Secretion of PDGF, endothelin-1, and angiotensin II encourages vasoconstriction, 
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vascular smooth muscle cell proliferation, and reactive oxygen species production15, 31, 32.  
Such shear stress-dependent regulation of reactive oxygen species has been shown to 
play a critical role in the development of atherosclerosis.    
 
Reactive Oxygen Species  
Reactive oxygen species (ROS) are produced in all aerobic cells and form as a 
byproduct of the normal metabolism of oxygen33.  Some are free radicals such as 
superoxide anion (O2•-), hydroxyl radical (HO•), nitric oxide (NO•), and lipid radicals, while 
others, like hydrogen peroxide (H2O2), peroxynitrite (ONOO-), and hypochlorous acid 
(HOCl), are not.  Disproportionate generation of ROS, beyond the capacity of balancing 
antioxidant systems, results in oxidative stress through oxidative damage to DNA, 
protein, carbohydrates, and lipids33, 34.  In fact, oxidative stress has been implicated in 
the development of numerous diseases including neurodegenerative diseases, 
premature aging, cancer, and vascular diseases35.   
 
Reactive oxygen species arise from many different cellular sources such as 
mitochondrial respiration, hemoproteins, peroxidases, lipoxygenase, cyclooxygenase, 
cytochrome P450, NADPH oxidase, xanthine oxidase (XO), and nitric oxide synthase 
(NOS).  Of these, NADPH oxidase, xanthine oxidase, and NOS have been most 
extensively studied in the cardiovascular system33, 34.  These enzymes use various 
substrates as electron sources to reduce molecular oxygen to superoxide or hydrogen 
peroxide.  Reduction of oxygen by one electron results in superoxide, while a two 
electron reduction, or dismutation of O2•- by superoxide dismutase (SOD), produces 
H2O236. Accumulating O2•- and H2O2 generated by these oxidases can further shift 
cellular redox balance by acting as a source of other ROS molecules.  For example, 
endothelial NOS (eNOS) requires tetrahydrobiopterin (BH4) and L-arginine to form NO•37. 
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Without one or the other, eNOS becomes uncoupled and produces O2•- and H2O238, 39.  
This dramatically reduces the bioavailability of the antioxidant NO• and allows radicals it 
might normally react with to attack other targets.  Furthermore, when eNOS is partially 
uncoupled, both O2•- and NO• are produced, can react to generate the highly reactive 
ONOO-, and lead to a dramatic increase in oxidative stress33.  There is substantial 
evidence to suggest that these enzymes systems contribute significantly to such 
overproduction of ROS in the shear stress-dependent pathogenesis of atherosclerosis. 
  
ROS and Atherosclerosis 
ROS have been linked to atherosclerotic plaque formation in both animal models and 
human studies.  In hypercholesterolemic rabbits, atherosclerosis resulting from diet was 
linked to XO-induced oxidative stress via the XO inhibitor oxypurinol40.  Moreover, in 
diseased human coronary arteries, electron spin resonance experiments found 
activation of both NADPH oxidase and XO41.  NADPH oxidases have also been found to 
be activated, with concomitant O2•- production, in the vessels of atherosclerotic rabbits42.  
Additionally, mice lacking a critical NADPH oxidase subunit, p47 phox, develop reduced 
plaque burden in the aorta compared to hypercholesterolemic control animals43.  
Peroxynitrite has also been implicated in atheroma formation.  3-nitrotyrosine, a marker 
of NO-mediated oxidative damage, was found in human atherosclerotic tissue, while 
LDL isolated from lesions was shown to be nitrated44-46.   
 
The pathological effects of ROS in the vasculature can be correlated to stress in 
endothelial, vascular smooth muscle, and adventitial cells.  In endothelial cells, OS-
dependent ROS can mediate inflammatory pathways via increased nuclear factor-κB 
(NF-κB) translocation, expression of adhesion molecules, and monocyte adhesion47, 48.  
In addition, ROS generated by the endothelium promote atherogenic signaling 
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mechanisms in the vascular wall.  It has been shown that NADPH oxidase-dependent 
oxidative stress induces smooth muscle cell proliferation49, 50.  Also, reduction of NO• 
bioavailability results in hypertension by attenuating endothelium-dependent vessel 
dilation51.  O2•- and the NO• derivative ONOO- act to directly oxidize lipid proteins, 
specifically LDL to ox LDL52, 53.  ox LDL can promote apoptosis, smooth muscle cell 
proliferation, and also act as powerful monocyte chemoattractant, upregulating 
proatherogenic molecules like MCP-1, IL-1β, LOX-1 and PAI-154-57.    
 
Despite the pathological consequence of oxidative stress, transient subtoxic levels of 
ROS have recently been associated with several vital signaling pathways.  Low levels of 
H2O2, produced in response to extracellular stimuli such as cytokines, neurotransmitters, 
peptide growth factors, and hormones, can affect protein function via oxidation of critical 
cysteine residues. This mechanism has been shown to influence the behavior of 
transcription factors, phospholipases, protein kinases and phosphatases, ion channels 
and G proteins58-60.  As a result, hydrogen peroxide is considered a ubiquitous 
intracellular messenger at subtoxic concentrations.  It has been shown to critically affect 
PDGF-, EGF-, and angiotensin II-dependent signaling and regulate targets such as 
protein tyrosine phosphatases (PTP) and lipid phosphatase PTEN61-65.  This concept 
suggests that reactive oxygen species may play dual roles in the endothelium, 
contributing to the atheroprotective functions of laminar shear stress, as well as the 
inflammatory pathways induced by disturbed flow conditions66-68. 
 
Shear Stress and ROS Production  
Laurindo et al. were the first to described flow-dependent generation of ROS in 
endothelial cells.  In both ex vivo and in vivo experiments using rabbit aortas, they 
established that short-term application of unidirectional shear stress stimulated O2•- 
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production69.  In vitro shear systems have subsequently demonstrated that LS stimulates 
ROS production acutely, but transient elevation returns to basal levels within a few 
hours66.  However, unlike LS, OS promotes sustained ROS production, maintaining 
elevated levels as long as cells are exposed to it 66, 70, 71.   
 
Many of the previously described ROS sources have been implicated in OS-mediated 
ROS generation.  Several groups have found that oscillatory shear stress is a potent 
stimulator of O2•- in endothelial cells via the NADPH oxidase66, 70.  Moreover, McNally et 
al. showed that OS induces NADPH oxidase-dependent hydrogen peroxide, which shifts 
the balance of xanthine dehydrogenase and XO to promote additional O2•-72.  Work by 
Hsiai et al. also indicated that OS causes elevated peroxynitrite production73.  These 
differences in LS- versus OS-dependent ROS production contribute greatly to 
pathological cellular behavior.  
 
We and others have found that OS-stimulated ROS production leads to ICAM-1, VCAM-
1, and E-selectin expression, and monocyte adhesion8, 66, 71, 74.  Conversely, laminar 
shear stress acts to reduce ROS levels and subsequent monocyte attachment75, 76.  The 
mechanism by which LS restricts such oxidative stress remains unclear.  In the following 
study, we propose that mechanosensitive antioxidants play a considerable role in 
laminar shear-dependent redox balance and atheroprotection.  
 
 Antioxidants and Laminar Shear Stress 
Antioxidant defense systems are critical to the protection of cellular macromolecules.  
They work to maintain a reductive cytosolic environment using both catalytic and 
nonenzymatic processes.  In particular, it has been hypothesized that antioxidants are 
likely to regulate intracellular hydrogen peroxide in a localized manner.  Production of 
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H2O2 occurs where needed for intracellular signaling, while hydrogen peroxide 
molecules diffusing away from the site of action are destroyed77.  Numerous studies 
suggest that steady laminar flow promotes such a reducing environment in endothelial 
cells, decreasing both inflammation and apoptosis27.  In fact, laminar shear stress has 
been shown to regulate several antioxidants including heme oxygenase-1 (HO-1), ferritin 
heavy chains (FTH), NADPH:quinone oxidoreductase-1 (NQO1), glutamate-cysteine 
ligase modifier subunit (GCLM), thioredoxin reductase1 (TXNRD1), glutathione 
reductase (GSR), endothelial nitric oxide synthase (eNOS), superoxide dismutase, 
glutathione (GSH) and thioredoxin (TRX)27, 66, 75, 76, 78-80.   
 
Many of these genes are regulated through a conserved antioxidant response element 
(ARE) or ARE-like transcriptional regulatory sequence in their promoter75, 80, 81.  The 
ARE, also called the electrophile response element (EpRE), is a cis-acting DNA 
regulatory element with a core sequence of 5’-RTGACNNNGC-3’81-83.  Transcription 
factor NF-E2-related factor 2 (Nrf2), a basic leucine zipper protein (bZIP), activates the 
ARE and its downstream genes by binding to the consensus sequence.  Under 
homeostatic conditions, the cytoskeleton binding protein Kelch-like ECH-associated 
protein 1 (Keap1) binds Nrf2 in the cytoplasm and targets it for degradation via the 
ubiquitin-proteasome system.   However, when cells are exposed to stress, Nrf2 is 
released and travels to the nucleus, where it forms a heterodimer with another bZIP, 
Maf, and binds to the ARE81-85.  Interestingly, recent reports have shown that Nrf2 and 
the ARE are both sensitive to laminar shear stress80, 82, 85, 86.   These findings suggest a 
mechanistic pathway for the atheroprotective effects of laminar shear stress and provide 
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Peroxiredoxins (PRX)  
Recently, a new group of ubiquitous antioxidant proteins has been acknowledged in 
yeast, plant and animal cells species.  The peroxiredoxins (PRX) are thiol specific-, non-
selenium containing enzymes that use redox-active cysteines to reduce peroxides and 
eliminate ONOO-.  They are produced at high levels in the cell, having been reported to 
comprise 100 nanograms to a few micrograms per milligram of soluble protein in 
mammalian cells87, 88.  Based on conserved cysteine residues, six isoforms of 




Figure 1.5  Peroxiredoxin family members reduce hydrogen peroxide in cells.        
(A) Mammalian PRX exist in three classes and contain either one or two conserved 
cysteine residues. Figure reprinted with permission35. Copyright © 2002 Maney 
Publishing. (B) Active PRX exist in a reduced state. Upon oxidation by hydrogen 
peroxide, they can either be inactivated by further oxidation or return to their active state 
with the help of an electron donor such as thioredoxin. Figure reprinted with 
permission77.  Copyright © 2005 Elsevier. 
 
Peroxiredoxin isoforms can be divided into three subcategories (Figure 1.5). Typical 2-
Cys PRX contain both the N-terminal and C-terminal conserved cysteine residues and 
require both of them for catalytic function.  PRX 1, 2, 3, and 4 are typical 2-cys PRX and 
form homodimeric associations in a head-to-tail fashion upon oxidation35, 88.  Atypical 2-
Cys and 1-Cys PRX proteins possess only the N-terminal “peroxidatic” Cys, but atypical 
2-Cys PRX requires an additional non-conserved cysteine for catalytic activity77.  PRX 5 
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and 6 are atypical 2-Cys and 1-Cys PRX, respectively, and complete their catalytic cycle 
as monomers35.   
 
The peroxidase reaction for each subclass of PRX includes an identical first step where 
the peroxidatic cysteine attacks the peroxide substrate and is oxidized to a cysteine 
sulfenic acid.  For typical 2-Cys peroxiredoxins, this intermediate can either be further 
oxidized and inactivated by hydrogen peroxide, or it can react with the C-terminal 
cysteine in the other subunit to form an intermolecular disulfide35, 77, 88.  The catalytic 
cycle is completed when the sulfinylated (Cys-SO2H) or dimeric PRX is reduced by 
sulfiredoxin or thioredoxin, respectively88-91.  For PRX 5, the sulfenic acid intermediate 
reacts with the sulfhydryl group of the C-terminal cysteine on the same molecule and 
forms an intramolecular disulfide.  As before, this disulfide is reduced via thioredoxin 
electron donation.  The reaction scheme for the catalytic cycle of 1-Cys PRX proteins 
uses a reacting thiol as a reducing substrate.  The disulfide bond is formed between the 
thiol and sulfinylated (Cys-SO2H) PRX.  Ground state is achieved by attack of a second 
thiol on the disulfide bridge92.  Although the identity of this thiol donor remains 
controversial, GSH, lipoic acid, and cyclophilin A have been proposed as reductants93, 94. 
 
Peroxiredoxins are prime candidates for regulators of local hydrogen peroxide signaling 
in endothelial cells.  They have been shown to be broadly distributed in the subcellular 
compartments of several mammalian cells types, and subsequently, have access to 
regional ROS production87, 88.  In addition, 2-Cys PRX exhibit a high degree of affinity for 
hydrogen peroxide; a concentration of less then 20 micromolar H2O2 results in half 
maximal PRX activity95.  Studies using siRNA and PRX-specific overexpression have 
shown that peroxiredoxin enzymes significantly affect the intracellular level of hydrogen 
peroxide.77  In fact, overexpression of PRX 1 and 2 blunts PDGF- and EGF-dependent 
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H2O2 production and TNF-α-induced NF-κB transcriptional activity96, 97.  PRX have also 
modulated signaling effects of these cytokines, affecting JNK, ERK, and p38 MAP 
kinase and blocking the induction of ceramide-dependent apoptosis98, 99.  These results 
suggest that PRX serve as important members of the signaling cascade by specifically 
destroying hydrogen peroxide molecules.     
 
Like many participants in intracellular signaling, peroxiredoxin proteins can be regulated 
at the transcriptional level and by post-translational modification.  In 2000, Ishii et al. 
found that oxidative stress promotes PRX 1 gene expression via the Nrf2 transcription 
factor in macrophages100.  Kim et al. also established Nrf2 as a regulator of PRX 1 in 
cancer cells exposed to hypoxia/reoxygenation83.  However, additional work in 
macrophage and monocytic cell lines identified activator protein-1 (AP-1) as the 
important transcription factor in tumor promoter-dependent PRX 1 expression101.  
Furthermore, recent studies have revealed that FOXO3A induces PRX 3, NFR-1 and 
GABPA affect PRX5, and Pax5 regulates PRX 6 gene expression, in cardiac fibroblasts, 
HeLa cells, and mouse B cells, respectively102-104.  
 
Additionally, PRX have been shown to be both phosphorylated and sulfinylated91, 105.   
Phosphorylation of PRX 1 and 2 at Thr90 by cyclin-dependent kinase (Cdk) results in a 
loss of peroxidase activity.  These results suggest that accumulation of hydrogen 
peroxide may be critical during the normal progression of the cell cycle77, 105.  Similarly, 
sulfinylation of PRX (conversion of Cys-SH to Cys-SO2H) causes reduction in 2-Cys 
PRX activity that can be rescued by sulfiredoxin, but not thioredoxin89.  This reversible 
inactivation is likely to accommodate the intracellular messenger function of hydrogen 
peroxide106.  As previously mentioned, hydrogen peroxide is likely tightly regulated.  
Protection from destruction by the large pool of PRX allows H2O2 concentration to 
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increase rapidly above a certain threshold at the site of signaling.  At the same time, the 
slow rate of PRX reactivation by sulfiredoxin allows enough time for hydrogen peroxide 
accumulation and signal cascade propagation64, 77.  
 
Recent studies have elucidated several functional roles for PRX.  Work by the A.B. 
Fisher group has shown the importance of PRX 6 in heart recovery following ischemia 
reperfusion injury and in protection from phospholipid peroxidation-mediated membrane 
damage107, 108.  PRX 2 has been found to regulate PDGF signaling and vascular 
remodeling, as well as cellular senescence and death65, 109, 110.  In addition, PRX 1 
affects NFκB signaling, PRX 4 is involved in acrosome formation during sperm 
development, and PRX 3 regulates mitochondrial apoptosis102, 111-113.  However, no 
studies have yet investigated the role of shear stress on PRX regulation in endothelial 
cells.  Based on their wide variety of physiological functions, we believe that 
peroxiredoxin antioxidants are likely involved in the molecular mechanisms that control 
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The hemodynamic patterns generated by blood flow play an important role in the 
localized development of atherosclerosis.  Straight regions of the vasculature are 
considered “protected” from atherogenesis by high levels of unidirectional laminar shear 
stress (LS).  In contrast, plaque-prone areas in curves and bifurcations of the arterial 
tree correspond to locales exposed to low or unstable shear stress including oscillatory 
shear stress (OS)1, 2.  Numerous studies have linked these local mechanical forces to 
the behavior of the exposed endothelium.  Endothelial cells experiencing disturbed flow 
exhibit oxidative stress and subsequent inflammatory molecule expression and 
monocyte recruitment as early signatures of atherosclerosis3, 4.  In vitro studies have 
established that OS increases reactive oxygen species (ROS) levels in endothelial cells, 
whereas LS blocks such responses.  While OS-induced oxidative stress and 
inflammation have been shown to occur in an NADPH oxidase-dependent manner, the 
atheroprotective mechanisms of LS remain unidentified5-7.   
 
Antioxidant defense systems are likely to play an important part in this LS-dependent 
balance of ROS.  As antioxidant proteins, all six mammalian peroxiredoxins (PRX) 
reduce harmful hydrogen peroxide and have been linked to the prevention of oxidative 
stress, apoptosis, and inflammation8, 9.  However, PRX have been overlooked in 
endothelial cells and the oxidative pathways involved in plaque development.  In the 
following study, we investigate the expression of all PRX family members in response to 
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physiologically relevant hemodynamic patterns and identify PRX 1 as an important 
regulator of endothelial cell redox balance. 
 
Project Objective  
The goal of this project is to investigate how atherogenic and atheroprotective fluid flow 
profiles regulate peroxiredoxin proteins and to identify how mechanosensitive 
antioxidants, specifically PRX 1, play a role in redox regulation.  An understanding of 
how PRX 1 is regulated and what role it plays physiologically may contribute important 
insights into endothelial cell biology and vascular diseases.       
 
Overall Hypothesis 
Unidirectional laminar shear stress (LS), compared to disturbed oscillatory shear 
stress (OS), promotes increased expression of peroxiredoxins via transcriptional 
regulation, which in turn influences the balance of reactive oxygen species in 
endothelial cells.  This hypothesis was tested according to three specific aims using 
cellular, molecular, and biochemical studies of bovine aortic endothelial cells (BAEC).  
Bovine aortic endothelial cells were chosen as an in vitro model to represent the arterial 






















Figure 2.1 Overall Hypothesis  Atheroprotective laminar shear stress reduces reactive 












Specific Aim 1 
Investigate shear stress-dependent expression and subcellular localization of 
peroxiredoxin family members in aortic endothelial cells. 
 
Hypothesis: Laminar shear stress, compared to oscillatory shear stress, promotes 












Figure 2.2  Experimental layout for Specific Aim 1 
 
To determine the effect of different hemodynamic profiles on peroxiredoxin family 
members, we examined overall protein expression and protein localization in response 
to shear stress (Figure 2.2).  An in vitro shear system, the modified cone-and-plate 
viscometer, was used to expose bovine aortic endothelial cells to chronic unidirectional 
laminar shear stress or oscillatory shear stress.  Immunoblot and immunofluorescence 
staining were employed to characterize shear stress-dependent expression patterns and 





Specific Aim 2 
Identify the role of PRX 1 in shear stress-dependent reactive oxygen species 
regulation.  
 
Hypothesis: Laminar shear stress maintains low levels of reactive oxygen species in 











Figure 2.3  Experimental layout for Specific Aim 2 
 
Characterization data from Specific Aim 1 demonstrated that intracellular PRX 1 is 
upregulated by chronic laminar shear stress and is strategically located to access 
reactive oxygen species from membrane-bound oxidases.  To establish the physiological 
importance of PRX 1 in shear stress-dependent redox balance, we examined the role of 
PRX 1 in LS-mediated ROS regulation (Figure 2.3).  The depletion of individual PRX 
from cellular systems provided a useful tool to study the functional role of each PRX 
isoform.  In these studies, specific siRNAs were used to knockdown PRX 1 expression in 
endothelial cells.  Subsequently, shear stress-induced hydrogen peroxide levels were 
assessed via Amplex Red fluorescence assay.  Additional experiments using PRX 5 
siRNAs further established the functional importance of PRX 1, amongst other PRX 
family members, in endothelial cell redox regulation. 
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Specific Aim 3 
Investigate the mechanism of shear stress-dependent PRX 1 expression in aortic 
endothelial cells. 
 
Hypothesis: Laminar shear stress induces PRX 1 protein expression via transcriptional 
regulation of the Prdx1 gene. 
 
Specific Aim 3









Figure 2.4  Experimental layout for Specific Aim 3 
 
In Specific Aims 1 and 2, PRX 1 was found to be a novel mechanosensitive antioxidant 
playing an important role in shear stress-dependent regulation of endothelial cell biology.  
To identify the mechanism by which laminar shear stress promotes protein expression of 
PRX 1, we investigated the regulation of the Prdx1 gene (Figure 2.4).   Here, Prdx1 gene 
expression was assessed in response to unidirectional laminar shear stress or 
oscillatory shear stress, as well as a possible transcription factor (Nrf2).  mRNA 
degradation and Prdx1 promoter studies further elucidated the critical regulation points 
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LAMINAR SHEAR STRESS UPREGULATES PEROXIREDOXINS 
(PRX) IN ENDOTHELIAL CELLS – PRX 1 AS A 
MECHANOSENSITIVE ANTIOXIDANT 
 
The overall objective of this thesis study is to examine the regulation of peroxiredoxin 
(PRX) family members in endothelial cells (EC) and to identify their role in shear stress-
mediated redox control.  Via Specific Aim 1, we sought to investigate protein expression 
and subcellular localization of peroxiredoxins in response to physiologically relevant 
flow.  Subsequently, the goal of Specific Aim 2 was to establish the functional 
importance of any mechanosensitive PRX in reactive oxygen species (ROS) 
management.  To achieve these aims, an in vitro shear system was employed to 
generate atheroprotective or atherogenic shear stress patterns.  For the first time, we 
have characterized the mechanosensitive nature of PRX antioxidants, able to locally and 
globally regulate hydrogen peroxide levels in endothelial cells. 
 
Summary 
Shear stress plays a significant role in endothelial cell biology and atherosclerosis 
development.  Previous work by our group has shown that fluid flow stimulates important 
functional changes in cells through protein expression regulation.  Peroxiredoxins are a 
novel family of antioxidant enzymes, but have yet to be investigated in response to shear 
stress.  Studies have shown that oscillatory shear stress (OS) increases reactive oxygen 
species concentration in endothelial cells, whereas laminar shear stress (LS) blocks this 
response. We hypothesized that PRX are responsible for the anti-oxidative effect of LS.  
To test this hypothesis, bovine aortic endothelial cells (BAEC) were subjected to LS (15 
dyn/cm2), OS (± 5 dyn/cm2, 1 Hz) or static (ST) conditions for 24 hours.  Using Western 
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blot and immunofluorescence staining, all six isoforms of PRX were identified in BAEC. 
When compared to OS and ST, exposure to chronic LS upregulated PRX 1 levels 
intracellularly.  LS also increased expression of PRX 5 relative to static controls, but not 
OS.  PRX exhibited broad subcellular localization, with distribution in the cytoplasm, 
Golgi, mitochondria, and intermediate filaments.  In addition, PRX 1-knockdown, using 
specific small interference RNA (siRNA), attenuated LS-dependent ROS reduction in 
BAEC.  However, PRX 5 depletion did not.  Together, these results suggest that PRX 1 
is a novel mechanosensitive antioxidant, playing an important role in shear-dependent 
regulation of endothelial biology and atherosclerosis.  
 
Introduction 
Shear stress acting on the blood vessel wall plays an important role in the development 
of atherosclerosis.  Straight regions of the arterial tree are considered “protected” from 
atherogenesis by high levels of unidirectional laminar shear stress1, 2.  In contrast, 
plaque-prone areas in curves and bifurcations of the vasculature correspond to locales 
exposed to low or unstable shear stress including oscillatory shear stress2-4.  These local 
mechanical forces have been correlated to the behavior of the exposed endothelium5-7.   
 
Endothelial cells exposed to disturbed flow experience oxidative stress, inflammatory 
molecule expression, and monocyte recruitment as early signatures of atherosclerosis8-
12.  In vitro studies have established that OS is a potent stimulator of reactive oxygen 
species production in EC, and quantitative measurements by our group showed a 
significant increase in both OS-dependent superoxide (O2·-) and hydrogen peroxide 
(H2O2) production12-14.  We found that OS-stimulated ROS occurs in an NADPH oxidase-
dependent manner and leads to inflammatory responses (ICAM-1 expression and 
monocyte adhesion)13, 15.  Conversely, LS acts to reduce ROS production and 
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subsequent inflammatory response13, 16, 17.  Nevertheless, the mechanism by which LS 
restricts oxidative stress remains unclear.   
 
Antioxidant defense systems are critical to the protection of cellular macromolecules.  
They work to maintain a reductive cytosolic environment using both catalytic and non-
enzymatic processes18.  In particular, it has been hypothesized that antioxidants are 
likely to regulate intracellular hydrogen peroxide in a localized manner.  Production of 
H2O2 occurs where needed for intracellular signaling, while hydrogen peroxide 
molecules diffusing away from the site of action are destroyed19.  Recently, a new group 
of ubiquitous antioxidant proteins has been acknowledged in yeast, plant, and animal 
cells.  The peroxiredoxins (PRX) are thiol specific-, non-selenium containing enzymes 
that use redox-active cysteines to reduce peroxides and eliminate ONOO-.  They are 
produced at high levels in the cell, having been reported to comprise 0.1-1% of soluble 
protein in mammalian cells20.  Based on conserved cysteine residues, six isoforms of 
peroxiredoxins (PRX 1-6) have been identified in mammalian systems, and a variety of 
investigations have described their functional roles in vascular remodeling, cancer and 
pulmonary and neurodegenerative diseases21-24.  However, no study has yet explored 
the role of shear stress on PRX regulation in endothelial cells. 
 
In this study, we tested the hypothesis that shear stress alters PRX function by 
regulating protein expression and localization, which in turn affect the redox status of 
endothelial cells.  Our studies show that all six forms of PRX are abundantly expressed 
in bovine aortic endothelial cells (BAEC) and that atheroprotective LS increased 
intracellular PRX 1 levels, compared to atherogenic OS.  In addition, PRX 1 knockdown 
experiments implicated PRX 1, but not PRX 5, as an important regulator of shear-
dependent cellular redox state.   
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Materials and Methods 
Endothelial Cell Culture 
Bovine aortic endothelial cells were obtained from Cell Applications Inc.  Cells were 
maintained in a standard humidified incubator (37°C, 5% CO2) in Dulbecco’s minimum 
Eagle’s medium (Gibco) supplemented with 10% fetal bovine serum (FBS, Atlanta 
Biologicals), heparin sodium (American Pharmaceutical Partners), endothelial cell 
growth supplement (isolated by us), and minimum non-essential amino acids (Gibco).  
BAEC from passage 8-15 were used in the following experimental protocols. 
   
Shear Stress Studies 
BAEC were grown to confluent monolayers in 100 mm tissue culture dishes (Falcon) and 
were subsequently exposed to static (ST) culture conditions or arterial levels of shear 
stress via cone-and-plate shear apparatus.  Atheroprotective LS at 15 dynes/cm2 was 
simulated by rotating a Teflon cone (0.5o cone angle) unidirectionally in medium as 
previously described by us25.  To mimic unstable atherogenic OS, the cone was rotated 
bidirectionally in medium using a stepping motor (Servo Motor) and computer program 
(DC Motor Company).  Endothelial cells were exposed to OS at ±5 dynes/cm2 with 
directional changes of flow at 1 Hz frequency 10.  All shear stress studies were performed 
in low serum (0.5% FBS) growth medium for 24 hours.  
 
Preparation of Whole Cell Lysate 
Following experimental treatment, cells were washed three times with ice cold 
phosphate buffered saline (PBS) and lysed with 600 µL lysis buffer (50 mM Tris-HCl, pH 
7.4 at 4oC, 1% Nonidet P40, 0.25% Na-deoxycholate, 150 mM NaCl, 1 mM EDTA, 30 
mM NaF, 40 mM ß-glycerophosphate, 10 mM Na4P2O7, 2 mM Na3VO4, 1 mM PMSF, 
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0.1% SDS).  The lysate was further homogenized by sonication.  The protein content of 
each sample was determined by Bio-Rad DC assay.    
 
Immunoblotting 
Aliquots of cell lysate (20-40 µg of protein each) were resolved by size on 12.5 or 15% 
SDS polyacrylamide gels and subsequently transferred to a polyvinylidene difluoride 
membrane (Millipore).  The membrane was incubated with primary antibody overnight at 
4 °C, followed by incubation with an alkaline phosphatase-conjugated secondary 
antibody for 1 hour at room temperature.  Protein expression was detected by a 
chemiluminescence method and the intensities of immunoreactive bands were 
determined via densitometry using the NIH Image program 26.  Primary antibodies 
specific for PRX 1, 2, 3, 4, 5, and 6 (Lab Frontier), phospho-eNOS (Ser1177), (Cell 
Signaling Technology), total eNOS (BD Biosciences Pharmingen) and actin (Santa Cruz 
Biotechnology) were used. 
 
Immunocytochemistry  
Following shear stress exposure or static culture, BAEC in 100 mm tissue culture dishes 
were washed three times with PBS.  Cells were fixed with 2% paraformaldehyde and 
permeabilized in 0.2% Triton-X 100.  Primary antibody in 3% bovine serum albumin 
(BSA) was applied overnight at 40C, followed by incubation with secondary antibody 
conjugated to Alexa Fluor 488 or 568 (Molecular Probes) for 1 hour at room 
temperature.  Nuclei were labeled with Hoechst stain in 3% BSA for 15 minutes at room 
temperature.  To identify mitochondria, cells were incubated with 100 nM Mitotracker 
Red CMXRos (Molecular Probes) in growth medium for 15 minutes at 370C prior to 
fixation.  All cells were mounted using the Prolong Antifade Kit (Molecular Probes) and 
fluorescence images were collected via confocal microscope (Zeiss LSM 510).  Primary 
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antibodies specific for PRX 1, 2, 3, 4, 5, and 6 (Lab Frontier), the Golgi marker GM 130 
(Transduction Laboratories), and the intermediate filament marker Vimentin (Sigma) 
were used.  
 
Small Interfering RNA (siRNA) 
Annealed siRNA duplexes and Oligofectamine (Invitrogen) transfection agent were 
applied to BAEC for 48-72 hours per manufacturer’s recommendation.  Control non-
silencing siRNA [sense: 5'-UUCUCCGAACGUGUCACGUtt, antisense: 5'-
ACGUGACACGUUCGGAGAAtt] (Qiagen), Alexa Fluor 546-labeled control non-
silencing siRNA (Qiagen), bovine PRX 1 siRNA [sense: 5'-
GUGCUUCUGUGGAUUCUCAtt, anti-sense: 5'-PhoUGAGAAUCCACAGAAGCACtt] 
(MWG), and bovine PRX 5 siRNA [sense; 5'-GUGGCAUGUCUGACCGUUAtt, 
antisense: 5'-PhoUAACGGUCAGACAUGCCACtt] (MWG) were used.  
 
Hydrogen Peroxide Detection 
Using a horseradish peroxidase-linked Amplex Red fluorescence assay, intracellular 
hydrogen peroxide production was measured via extracellular leakage of H2O2 from 
conditioned BAEC as previously described14.  Briefly, cells were exposed to either static 
culture conditions or shear stress in low serum culture medium.  After 24 hours, cells 
were washed twice with Krebs Ringer Phosphate (KRP) buffer and incubated with 5 µM 
Amplex UltraRed (Molecular Probes) and 0.1 U/ml horseradish peroxidase type II 
(Sigma-Aldrich) in KRP for 40 minutes.  To identify the hydrogen peroxide-specific 
signal, control samples were co-incubated with 500 U/ml catalase.  Triplicate reading 
were taken in a 96-well plate using 100 µl samples of media, and fluorescence was 
detected via plate reader at excitation and emission of 530 nm and 580 nm, respectively.  
Hydrogen peroxide levels were calculated in terms of catalase-inhibitable signal and 
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were normalized to cellular protein as measured by the Bio-Rad DC assay.  H2O2 
concentrations were estimated using a standard curve. 
 
Statistical Analysis 
For all quantitative data collected, statistical analysis was assessed by Student’s t test 
using Microcal Origin statistical package.  A significant difference between control and 
treatment groups was defined as p<0.05 for three or more independent experiments.  
 
Results 
LS upregulates PRX 1 expression in cell lysates. 
Our previous work established that fluid shear stress critically affects endothelial cell 
function by regulating protein expression patterns.  The PRX family is undeniably 
significant to cellular physiology and pathology, but remains understudied in the fluid 
flow field.  This led us to investigate whether shear stress regulates the expression of 
mammalian PRX in BAEC.  To this end, total BAEC lysates were collected after 24 
hours of static culture, LS (15dynes/cm2), or OS (±5dynes/cm2) and analyzed by 
Western blot using PRX-specific antibodies.  In these studies, static conditions (ST), 
cells cultured under no shear stress, were examined as a control for shear stress 
exposure.  As previously described, physiologically “normal” arterial endothelial cells do 
not encounter chronic static conditions, but rather experience continuous fluid flow.  
Therefore, LS is a more relevant control, representing a healthy state, which we will 
compare to OS, the disease state.  As such, endothelial cell alignment, phosphorylated 
endothelial nitric oxide synthase (eNOS), and total eNOS were also assessed as internal 
LS-dependent controls (Figure 3.1).  With this in mind, all six PRX were detected in 
BAEC and densitometric analysis indicated the level of PRX 1 was significantly 
increased by LS compared to OS and static controls.  In addition, PRX 5 expression was 
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significantly increased by LS with respect to static conditions, but was not statistically 
different from OS (Figure 3.1).  Secreted forms of PRX 2, 4, and 6 were also detected in 
conditioned media following chronic LS (Figure A.1).  However, we could not exclude 
cellular damage as a contributing factor in these findings.  Therefore, our data suggest 
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Figure 3.1  PRX 1 is upregulated by LS.  Confluent BAEC were exposed to LS, OS or 
static conditions for 1 day, and cell lysates were obtained. (A) Equal aliquots of protein 
(20-40µg) were analyzed by Western blot using antibodies specific to PRX 1-6.  peNOS, 
teNOS, and actin blots were used as shear stress controls and internal loading controls, 
respectively.  (B) Densitometric analysis was used to quantify the intensity of each band 
and the average values (mean + SEM, n=12) are shown in bar graphs as % of static 
control.  * p<0.05 indicates significance compared to static control (ST). ** p<0.05 
indicates significance compared to OS.  
 
PRX exist in various subcellular locations throughout BAEC. 
Via Western blots, we have thus far found that shear stress regulates PRX 1 and 5 
expression in BAEC.  Based on the large number of PRX family members, we 
hypothesized that individual PRX likely play important roles in specific subcellular 
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compartments.  To investigate the intracellular distribution of PRX, confocal 
immunofluorescence staining studies were performed.  This study revealed data 
consistent with Western blot analysis of shear-induced protein expression in BAEC.  
Image analysis of staining intensities indicated that PRX 1, increased after 24 hours of 
LS compared to OS and static conditions (Figure 3.2A). 
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Figure 3.2  LS stimulated PRX 1 expression in BAEC.  Confluent BAEC were 
exposed to LS, OS or static conditions for 1 day as in Figure 3.1.  Cells were stained 
using antibodies specific to PRX 1-6. Secondary antibodies conjugated to Alexa Fluor 
488 (green) were imaged by confocal microscopy. Nuclei were counter-stained with 
Hoechst dye (blue).  Arrows indicate unique subcellular staining patterns of each PRX.   
 
In addition to the shear-dependency, Figure 3.2 also showed that PRX members 
exhibited assorted staining patterns.  This result raised two interesting questions: 1) Are 
PRX located in specific subcellular locations and 2) does shear stress alter this 
subcellular localization?  In order to clearly characterize the location of each PRX within 
specific subcellular compartments, colocalization staining was performed in static BAEC 
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Figure 3.3  PRX are located in various subcellular organelles in BAEC.  Static 
BAEC were co-stained for PRX 1-6 and subcellular organelles using PRX-specific 
antibodies (green), as in Figure 3.2, and organelle-specific markers (red).  Nuclei were 
counterstained with Hoechst dye (blue).  Center panels: Mitochondria, Golgi, and 
intermediate filaments are stained with Mitotracker CMXRos, GM 130 antibody and 
Vimentin antibody, respectively.  GM 130 and Vimentin were visualized by secondary 
antibodies conjugated to Alexa Fluor 568 (Red).  Merged images are shown in the right 
panel. Yellow staining indicates colocalization.   
 
using PRX-specific antibodies and organelle-specific markers for Golgi (GM 130), 
endoplasmic reticulum (KDEL receptor, data not shown), lysosome (cathepsin S, data 
not shown), intermediate filament (Vimentin) and mitochondria (Mitotracker).  PRX 1 
staining (green) overlapped with the Golgi marker staining (red), shown as yellow in the 
merged image (Figure 3.3A), suggesting that PRX 1 exists in the Golgi apparatus.  In 
addition, PRX 2, 4, 5 and 6 also appeared to be found in the Golgi (Figure 3.3B, E, F, 
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and G).  The PRX 3 staining pattern was distinctly different from other PRX, showing 
clear colocalization with the mitochondria marker (Figure 3.3D).  Interestingly, PRX 2 
staining revealed colocalization with the intermediate filament marker (Figure 3.3C).  In 
addition to these subcellular localizations, PRX 1, 2, 4, 5 and 6 were also expressed in 
the cytosol (Figure 3.3A, B, C, E, F and G).  Next, we examined whether shear stress 
stimulated expression of PRX members in other subcellular locations.  Subcellular 
location did not appear to change in response to shear stress, although Golgi were 
located upstream of the direction of flow after chronic LS, consistent with previous 
reports (Figure 3.2A, B, D, E and F).    Taken together, these results clearly indicate that 
PRX are abundantly expressed throughout the subcellular organelles of endothelial 
cells.  
 
PRX 1 prevents oxidative stress in endothelial cells exposed to LS.   
PRX 1 is a prominent antioxidant and our data indicates its expression is highly 
upregulated by LS 27.  Consequently, we investigated whether PRX 1 was responsible 
for the decreased ROS levels in endothelial cells exposed to LS.  The depletion of 
individual PRX from cellular systems provides a useful tool to study the functional role of 
each PRX isoform.  Here, specific siRNAs were used to knockdown either PRX 1 or 
PRX 5 protein levels in order to investigate PRX-dependent ROS accumulation.  
Western blots with isoform-specific PRX antibodies were used to determine the efficacy 
and specificity of these siRNAs.  Compared to non-silencing siRNA and Alexa Fluor 546-
labeled non-silencing siRNA (50 nM each), 48 hour-treatment of BAEC with PRX 1 
siRNA dramatically reduced (by 75% of non-silencing control) expression of PRX 1, at a 
concentration as low as 10nM (Figure 3.4A).  As shown in Figure 3.4B, 10nM PRX 5 
siRNA also effectively reduced PRX 5 expression (by 90% of non-silencing control).  Via 
Western Blots, the specificity of PRX 1 and 5 siRNAs were assessed by examining the 
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expression of all other PRX family members (Figure 3.4A and B).  Using isoform-specific 
PRX antibodies, we found that these siRNAs had no significant effect on other PRX, 
indicating that they exclusively targeted PRX 1 or 5, respectively, amongst all PRX 
family members (Figure 3.4A and B).  Therefore, PRX 1 and 5 siRNAs were confidently 

























Figure 3.4  PRX 1 and PRX 5 siRNAs specifically reduce PRX 1 and PRX 5 protein 
expression, respectively.  BAEC were transfected with either 50nM non-silencing 
siRNA (NS), 50nM Alexa Fluor 546-labeled siRNA (Alexa), or PRX 1 (A) or PRX 5 (B) 
siRNAs (10, 20, 50 and 100nM) for 48 hours.  Cell lysates were analyzed by Western 
Blot with PRX-specific antibodies, as indicated.  actin was used as an internal control.   
 
It has been well established that chronic exposure of endothelial cells to OS stimulates, 
while LS inhibits, ROS production13, 14, 17, 28, 29.  Utilizing an Amplex Red assay in the 
presence or absence of catalase, we verified that hydrogen peroxide levels were 87% 
less in BAEC exposed to LS compared to those treated with OS (Figure 3.5A).  Using a 
standard hydrogen peroxide dose curve, we also found that the relative hydrogen 



































   
   
   
   
   























































































































   
   
   
   
   
   













































   
   
   
   
   
   









Figure 3.5  PRX 1 knockdown increases H2O2 production in BAEC, while PRX 5 
knockdown does not.  Catalase-inhibitable hydrogen peroxide levels were assessed 
via Amplex Red Assay and average values (mean + SEM, n=6-12) are shown in bar 
graphs as % of non-silencing (NS) siRNA-treated static controls. (A) Confluent BAEC 
were exposed to ST, LS, or OS for 24 hours prior to assay.  (B) A hydrogen peroxide 
dose curve was used to estimate relative hydrogen peroxide concentrations in cells 
conditioned with shear stress.  (C) BAEC were transfected with either non-silencing or 
PRX 1 siRNA (10nM) for 48 hours and then exposed to ST, LS, or OS for 24 hours, prior 
to assay.  (D) BAEC were transfected with either non-silencing or PRX 5 siRNA (10nM) 
for 48 hours and then exposed to ST, LS, or OS for 24 hours, prior to assay.  * p<0.05 
designate significance between indicated groups.  
 
cellular concentrations (Figure 3.5B).  To determine whether PRX 1 was responsible for 
the LS-dependent decrease in ROS levels in BAEC, we knocked down PRX 1 using 
PRX 1 siRNA as indicated above (Figure 3.4A).  PRX 1 depletion significantly increased 
catalase-inhibitable hydrogen peroxide by two fold above non-silencing controls, in 
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static- LS-, and OS-treated BAEC (Figure 3.5C).  To investigate whether this was a 
global effect of mechanosensitive PRX family members, we also knocked down PRX 5 
using PRX 5-specific siRNA.  However, when compared to non-silencing controls, PRX 
5 depletion had no significant effect on hydrogen peroxide levels in any group (Figure 
3.5D).  Taken together, these data suggest that PRX 1 is a critically important regulator 
of ROS levels in both a basal and shear-dependent manner. 
 
Discussion 
Through protein expression analysis and subsequent functional studies, we have 
discovered PRX 1 as a mechanosensitive antioxidant.  Data to support this concept 
include: (1) PRX 1 is upregulated intracellularly by chronic LS compared to OS; (2) PRX 
exhibit broad staining patterns in BAEC and localize in important cellular structures; (3) 
ROS production is significantly reduced in cells exposed to chronic LS, and (4) this effect 
can be attenuated by PRX 1 depletion, but not PRX 5 depletion.   
 
Through this work, we reveal for the first time that PRX are regulated by shear stress in 
endothelial cells. Previous studies have shown that other antioxidants are also controlled 
by shear stress.  LS has been shown to regulate antioxidant genes including eNOS, 
Cu/Zn superoxide dismutase (SOD), Mn SOD, glutathione peroxidase (GPX), 
glutathione (GSH) and thioredoxin (TRX)6, 13, 17, 30-34.  In addition, Chen et al. observed 
that many genes protective against oxidative stress are induced by exposure to 
prolonged LS.  They have also noted that such genes are regulated through a 
conserved, shear-sensitive antioxidant response element (ARE)35, 36.  In support of our 
finding that PRX 1 expression is LS-dependent, recent work has shown that PRX 1 is a 
target gene of nuclear factor (erythroid-derived 2)-related factor 2 (Nrf2), a key 
transcription factor which binds to ARE37.  Collectively, these studies indicate that cells 
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possess an elaborate system of shear-responsive antioxidants and that each may play 
an independent role to mediate oxidative stress and modulate redox-sensitive signaling 
pathways.  
 
The ubiquitous nature of the PRX family itself exemplifies this concept.  
Immunofluorescence microscopy revealed PRX throughout the cellular milieu of BAEC, 
colocalizing with the cytoplasm, Golgi apparatus, mitochondria, and intermediate 
filaments.  These observations were consistent with previously reported localization 
studies in other cell types, but we are the first to report an apparent PRX 2 colocalization 
with vimentin38, 39.  This costaining of PRX 2 with vimentin suggests that it may be 
located in the intermediate filament, but further studies will be necessary to confirm this 
finding.  Though detection of PRX in the Golgi body likely reflects protein processing or 
packaging, localization within other organelles indicates that PRX may act both globally 
and in a site-specific manner to regulate ROS in endothelial cells.  In the endothelium, 
ROS, such as O2•- and H2O2, arise from several sources including NADPH oxidase, 
xanthine oxidase, mitochondrial oxidase, cytochrome P450 and uncoupled nitric oxide 
synthase40, 41.  At relatively low concentrations, ROS play critical roles in redox signaling 
and normal cell function.  However, higher concentrations of ROS induce oxidative 
damage of DNA, proteins, carbohydrates and lipids 42-44.  This damage has been shown 
to critically affect cellular function and apoptosis when it occurs in mitochondria, 
lysosomes, and nuclei45-47.  In addition, cytosolic proteins modified by ROS have been 
shown to affect local cell signaling and, collectively, the redox status of the cell48, 49.  
Ubiquitous distribution of PRX in BAEC may reflect diverse sources of ROS throughout 
the cells and provide protection for important macromolecules and structures against 
local ROS production.  In addition, widespread allocation of PRX may also be important 
for comprehensive management of the overall oxidative state of cells.   
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Several studies have shown that oxidative stress is regulated by shear stress in 
endothelial cells13, 14.  We have previously published that both LS and OS stimulate ROS 
production acutely, but the ROS transiently elevated by LS returns to basal levels within 
a few hours13.  However, unlike LS, OS continues to increase ROS production, 
maintaining elevated levels as long as cells are exposed to OS 13, 29.  The mechanism by 
which ROS levels are lowered in cells exposed to chronic LS is undefined.  This study 
demonstrates that endothelial cells exposed to chronic LS express much more PRX 1 
compared to OS and static conditions.  These findings suggest that PRX 1 is 
upregulated by LS and that this may be responsible for LS-mediated decrease in ROS 
levels.   
 
As previously determined by electron spin resonance spectrometry and 
dichlorofluorescein-diacetate methods, endothelial cells exposed to OS produce 
significantly more superoxide and hydrogen peroxide than those in static culture14.  In 
contrast, endothelial cells treated with chronic, unidirectional high shear generate 
considerably less O2•-.  Here, we used Amplex Red assay as an independent method to 
measure ROS levels in BAEC.  Consistent with our previous reports, OS increased and 
LS decreased ROS production (Figure 3.5A).  The ROS measured by this assay was 
inhibitable by catalase, indicating that H2O2 is the primary ROS component.   
 
PRX 1 is the most abundant and ubiquitously distributed member of mammalian PRX27.  
Our current study demonstrated that PRX 1 is dramatically upregulated by chronic LS 
compared to OS and is located in the cytoplasm and Golgi.  Knockdown of PRX 1 using 
siRNA resulted in significantly higher ROS levels in BAEC exposed to LS, OS, and static 
conditions, while PRX 5 depletion did not.  Although PRX 1 knockdown did not fully 
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abolish the antioxidative outcome of LS, its significant effect was somewhat surprising 
considering the presence of other PRX family members and additional 
mechanosensitive antioxidant pathways.  In addition, PRX 5 depletion studies provide 
further evidence that PRX 1 is crucial to shear-dependent ROS regulation.  Altogether, 
these results indicate that chronic exposure to LS upregulates PRX 1 expression in 
order to keep ROS levels low in endothelial cells.  
 
In summary, we have shown that shear stress regulates expression of the PRX family 
and that PRX 1 plays a critical role in regulating ROS levels in endothelial cells.  
Furthermore, this discovery of PRX 1 as a mechanosensitive antioxidant may contribute 
important insights into endothelial cell biology and vascular diseases.   
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PRDX1 GENE IS UPREGULATED BY LAMINAR SHEAR STRESS 
IN PART BY NRF2 TRANSCRIPTION FACTOR                                   
 
In Chapter 3, we identified Peroxiredoxin 1 as a novel mechanosensitive antioxidant that 
plays an important role in shear stress-dependent regulation of endothelial biology.  In 
turn, the goal of Specific Aim 3 was to examine the pathway by which laminar shear 
stress, but not oscillatory shear stress, promotes the expression of PRX1 protein.  To 
achieve this aim, we investigated the regulation of bovine Prdx1, the gene encoding 
PRX 1, in response to different shear stress patterns and a potential transcription factor, 
nuclear factor (erythroid-derived 2)-related factor 2 (Nrf2).      
 
Summary 
Endothelial cells (EC) exposed to oscillatory shear stress (OS) experience oxidative 
stress as a signature of atherosclerosis.  Conversely, unidirectional laminar shear stress 
(LS) reduces reactive oxygen species (ROS) levels.  Previous studies by our group have 
found that fluid flow stimulates these important functional changes through gene and 
protein expression regulation.  More specifically, others have shown that LS induces 
many protective genes via a shear-sensitive antioxidant response element (ARE).  
Peroxiredoxins (PRX) are a family of antioxidant enzymes that remain understudied in 
the field of endothelial cell biology.  Recently, we showed that the protein Peroxiredoxin 
1 (PRX 1) is upregulated intracellularly by chronic LS, compared to OS and static (ST) 
culture.  In addition, PRX 1-knockdown attenuated LS-dependent ROS reduction in EC.  
Therefore, in this study, we hypothesized that shear-dependent PRX 1 expression may 
be regulated by the ARE through its transcription factor nuclear factor (erythroid-derived 
2)-related factor 2 (Nrf2).  Quantitative, real-time PCR indicated that LS increases Prdx1 
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mRNA in a time-dependent manner, compared to OS and ST.  Immunoblots also 
showed increased PRX 1 protein expression in response to Nrf2 adenovirus infection.  In 
addition, depletion of Nrf2 using specific siRNAs reduced Prdx1 expression both under 
static culture conditions and in response to LS.  These results indicate that shear-
dependent PRX 1 expression is regulated at the transcriptional level, and Nrf2 may play 
an important role in this mechanism.   
 
Introduction 
Shear stress produced by blood flow plays a critical role in the focal development of 
atherosclerosis.  At the cellular level, the exposed endothelium acts as sensor of this 
force, translating it into physiological or pathophysiological functions1.  In general, 
unidirectional laminar shear stress promotes an atheroprotective endothelial phenotype, 
while low, oscillatory shear stress stimulates atherogenic responses2-4.  It is well 
established that OS induces oxidative stress and inflammation via production of reactive 
oxygen species (ROS) like superoxide (O2•-) and hydrogen peroxide (H2O2)2, 5, 6.  In 
contrast, steady LS prevents inflammation and macromolecule damage by maintaining 
low ROS levels in endothelial cells7, 8.  Our group has demonstrated that this intracellular 
redox balance is critically dependent on shear stress-mediated gene and protein 
regulation.  In previous publications, we have shown that OS increases O2•- and H2O2 
through gene and protein expression of the cytokine Bone Morphogenic Protein 4 
(BMP4)9, 10.  Similarly, numerous studies suggest that steady laminar flow promotes a 
reducing environment in endothelial cells through the generation of antioxidants3.   
 
Antioxidant defense systems are crucial to the modulation of intracellular levels of ROS.  
They can directly scavenge ROS and disrupt the oxidative signaling cascades of 
pathological events such as inflammation, proliferation, and apoptosis11, 12.  The 
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peroxiredoxins (PRX) are a newly identified family of antioxidant enzymes that use 
redox-active cysteines to reduce peroxides and eliminate ONOO-.  Based on conserved 
cysteine residues, six isoforms of peroxiredoxin (PRX 1-6) have been identified in 
mammalian systems13, 14.  Recently, we examined the expression of all six PRX family 
members in bovine aortic endothelial cells (BAEC) exposed to shear stress.  Our data 
revealed that PRX 1 expression was elevated in response to LS, but not OS, and that 
this increase significantly influenced hydrogen peroxide levels15.  However, we have yet 
to identify the pathway by which atheroprotective laminar shear stress stimulates PRX 1 
protein production.   
 
Interestingly, laminar shear stress has been found to influence other antioxidants 
including heme oxygenase-1 (HO-1), ferritin heavy chains (FTH), NADPH:quinone 
oxidoreductase-1 (NQO1), glutamate-cysteine ligase modifier subunit (GCLM), 
thioredoxin reductase1 (TXNRD1), glutathione reductase (GSR), endothelial nitric oxide 
synthase (eNOS), superoxide dismutase (SOD), glutathione (GSH) and thioredoxin 
(TRX)3, 6-8, 16-18.  Many of these genes are regulated through a conserved antioxidant 
response element (ARE) or ARE-like transcriptional regulatory sequence in their 
promoter7, 11, 18.  The ARE, also known as the electrophile response element (EpRE), is a 
cis-acting DNA regulatory element with a core sequence of 5’-RTGACNNNGC-3’11, 19, 20.  
Transcription factor NF-E2-related factor 2 (Nrf2), a basic leucine zipper protein (bZIP), 
activates the ARE and its downstream genes by binding to this consensus sequence.   
Expectedly, several reports have shown that the ARE itself is sensitive to laminar shear 
stress, suggesting a conserved mechanism for the induction of cytoprotective, 




As such, we tested the hypothesis that laminar shear stress promotes the expression of 
PRX 1 protein via transcriptional regulation of the Prdx1 gene, through an ARE-
dependent pathway.  Our studies found that the bovine Prdx1 is upregulated by LS in a 
temporal manner compared to OS and static controls, and that Prdx1 mRNA stability is 
not affected by shear.  In addition, overexpression and knockdown of Nrf2 significantly 
induced and blunted Prdx1 gene expression, respectively.      
  
Materials and Methods 
Endothelial Cell Culture 
Bovine aortic endothelial cells were obtained from Cell Applications Inc.  Cells were 
maintained in a standard humidified incubator (37°C, 5% CO2) in Dulbecco’s minimum 
Eagle’s medium (Gibco) supplemented with 10% fetal bovine serum (FBS, Atlanta 
Biologicals), heparin sodium (American Pharmaceutical Partners), endothelial cell 
growth supplement (isolated by us), and minimum non-essential amino acids (Gibco).  
BAEC from passage 6-15 were used in the following experimental protocols. 
   
Shear Stress Studies 
BAEC were grown to confluent monolayers in 100 mm tissue culture dishes (Falcon) and 
were subsequently exposed to static (ST) culture conditions or arterial levels of shear 
stress via cone-and-plate shear apparatus.  Atheroprotective LS at 15 dynes/cm2 was 
simulated by rotating a Teflon cone (0.5o cone angle) unidirectionally in medium as 
previously described by us22.  To mimic unstable atherogenic OS, the cone was rotated 
bidirectionally in medium using a stepping motor (Servo Motor) and computer program 
(DC Motor Company).  Endothelial cells were exposed to OS at ±5 dynes/cm2 with 
directional changes of flow at 1 Hz frequency9.  All shear stress studies were performed 
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in low serum (0.5% FBS) growth medium, and shear stress exposure time was varied 
from 2 to 24 hours.     
 
Reverse Transcription and Quantitative, Real Time Polymerase Chain Reaction (PCR) 
Total RNA was isolated using an RNeasy Mini Kit (Qiagen) and reverse transcribed with 
random primers and a Superscript-II kit (Invitrogen) to synthesize first-strand cDNA.  The 
purified cDNA was amplified via quantitative, real-time PCR with a LightCycler (Roche 
Applied Science).  Reactions were performed in glass capillaries (Roche Applied 
Science) containing PCR buffer (20mM Tris-Cl, pH 8.4), 3mM MgCl2, 250µg/ml bovine 
serum albumin, 200µM deoxynucleotides, SYBR green (1:84,000 dilution), 0.05unit/µl 
Taq DNA polymerase (Denville), and Taq Start antibody (Clontech, 1:100 dilution).  The 
following primer pairs (5’to 3’) and reaction conditions (primer concentration, annealing 
temperature, extension time, and base pair yield, respectively) were used to amplify 
bovine Prdx1- forward: GACCCATGAACATTCCCTTG and reverse: 
GCTCTTCTGGACATCAGGCTTGAT (150nM, 62oC, 12 seconds, 283bp) and bovine 
Nrf2- forward:  TGCCACTGCTGTTTTAGACG and reverse: 
ACTGGCTGGAGTCTTCAGTGGAAA (250nM, 60oC, 12 seconds, 280bp).  Copy 
numbers were determined based on standard curves generated with bovine PRX1, Nrf2, 
and 18S templates.  PRX1 and Nrf2 mRNA copy numbers were normalized to 18S 
mRNA copy numbers, and gene products were verified by size via agarose gel 
electrophoresis. 
  
Prdx1 mRNA Stability  
Following exposure to chronic shear stress, conditioned BAEC were treated with the 
RNA polymerase II inhibitor 5,6-dichloro-1-β-D-ribofuranosylbenzimidazole (10µM DRB, 
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Calbiochem) to halt RNA synthesis.   Copy number of Prdx1 mRNA was assessed via 
quantitative, real time PCR at 0, 4, 8, and 12 hours after treatment.     
 
Plasmid Construction 
A 1,350 base pair fragment of the bovine Prdx1 promoter was isolated via PCR.  An 
XhoI site was added to the 5’ primer and a HindIII site was added to the 3’ primer- 
forward:  CGGCTCGAGTGGGCTCCTGTTTCCTATTC and reverse: 
CGGAAGCTTAATCACCGCTTTCTGCTTGT.  The PCR product was digested with 
XhoI/HindIII, gel-isolated, and subcloned into either pGL3-Basic (Promega) upstream of 
the luciferase reporter or β-CAT-pSP72 (Promega) upstream of the chloramphenicol 
acetyltransferase (CAT) reporter.  The sequences off all constructs were verified by DNA 
sequencing in both directions (Agencourt). 
 
Transfection and Reporter Gene Assay 
Transient luciferase reporter assays were performed using standard transfection 
methods.  Briefly, plasmid constructs (4.5µg of either pGL3 control or Prdx1 promoter-
pGL3 and 1.5 µg of β-galactosidase normalizing vecotor) were transfected into 90% 
confluent BAEC using Metafectene Pro (Biontex) in reduced-serum Opti-MEM (GIbco) 
according to manufacturer’s recommendation.  After 4 hours, media was replaced with 
growth media containing 10% FBS.  Cells were allowed to recover up to 48 hours and 
then were subjected an additional 6 hours of shear stress.   Luciferase activities were 
measured using the luciferase assay system (Promega), and β-galactosidase activities 
were assessed via plate reader (420nm).   Luciferase activities were normalized to β-






BAEC were infected with either control green fluorescent protein (Ad-GFP, 20 MOI) or 
wild type human Nrf2 adenovirus (Ad-wt hNrf2, GFP-tagged, 20, 40, 80 MOI) in serum-
free Dulbecco’s minimum Eagle’s medium.  After 6 hours, media was removed and 
replaced with 10% FBS growth media.  Cells were allowed to recover up to 48 hours and 
then were lysed for protein collection.  
       
Preparation of Whole Cell Lysate 
Following experimental treatment, cells were washed three times with ice cold 
phosphate buffered saline (PBS) and lysed with 600 µL lysis buffer (50 mM Tris-HCl, pH 
7.4 at 4oC, 1% Nonidet P40, 0.25% Na-deoxycholate, 150 mM NaCl, 1 mM EDTA, 30 
mM NaF, 40 mM ß-glycerophosphate, 10 mM Na4P2O7, 2 mM Na3VO4, 1 mM PMSF, 
0.1% SDS).  The lysate was further homogenized by sonication.  The protein content of 
each sample was determined by Bio-Rad DC assay.    
 
Immunoblotting 
Aliquots of cell lysate (20-40 µg of protein each) were resolved by size on 12.5% SDS 
polyacrylamide gels and subsequently transferred to a polyvinylidene difluoride 
membrane (Millipore).  The membrane was incubated with primary antibody overnight at 
4°C, followed by incubation with an alkaline phosphatase-conjugated secondary antibody 
for 1 hour at room temperature.  Protein expression was detected by a 
chemiluminescence method23.  Primary antibodies specific for PRX 1 (Lab Frontier) and 






Small Interfering RNA (siRNA) 
Annealed siRNA duplexes and Oligofectamine (Invitrogen) transfection agent were 
applied to BAEC per manufacturer’s recommendation.  In brief, 70-80% confluent BAEC 
were transfected with control or specific siRNA in reduced-serum Opti-MEM (GIbco).  
After 6 hours, media was supplemented to 10% FBS.  Cells were allowed to recover up 
to 48 hours, then were lysed, or subjected an additional 24 hours of shear stress.  
Control non-silencing siRNA sense: 5'-UUCUCCGAACGUGUCACGUtt, antisense: 5'-
ACGUGACACGUUCGGAGAAtt (Qiagen), Alexa Fluor 546-labeled control non-silencing 
siRNA (Qiagen), and bovine Nrf2 siRNA sense: 5'- CCAGACCACUCAGUGGAAUtt, anti-
sense: 5'- AUUCCACUGAGUGGUCUGGtt (MWG) were used. 
 
Statistical Analysis 
For all quantitative data collected, statistical analysis was performed by Student’s t test.  
Significance is defined as p<0.05 for three or more independent experiments.  
 
Results 
Prdx1 gene is upregulated by LS in a time-dependent manner. 
Recent work by our group linked the atheroprotective effects of laminar shear stress to 
the antioxidant protein PRX 1.  In previous studies, we showed that intracellular PRX 1 is 
significantly increased by LS compared to OS and mediates hydrogen peroxide levels in 
endothelial cells15.  To further investigate these findings, we sought to examine the 
pathway by which different shear stress patterns regulate PRX 1 protein expression.  As 
such, in vitro shear stress studies were carried out, and bovine Prdx1, the gene 
encoding PRX 1 protein, was assessed.  Total RNA was collected from BAEC following 
static culture, or 2, 4, 8 or 24 hours of LS (15dynes/cm2) or OS (±5dynes/cm2).  
Quantitative, real time PCR was used to determine Prdx1 mRNA copy number relative to 
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the internal control 18S.  Here, we found that Prdx1 increased in a time-dependent 
manner in response to laminar shear stress (Figure 4.1).  With as little as 2 hours of LS 
exposure, Prdx1 levels were elevated compared to static control.  Additionally, LS-
induced expression was statistically different from OS beginning at 4 hours and peaked 
at 24 hours with a 4.5 fold increase.  This shear stress-mediated regulation of Prdx1 
mRNA and the temporal nature of expression led us to believe that PRX 1 protein was 































































Figure 4.1  Prdx1 mRNA is upregulated by LS compared to OS in a time-dependent 
manner.  Confluent BAEC were exposed to LS, OS or static conditions for 2, 4, 8, or 
24h. Total RNA was collected and reverse-transcribed to synthesize first-strand cDNA, 
which was amplified via real-time, quantitative PCR.  mRNA copy numbers were 
determined based on standard curves generated with bovine Prdx1 and 18S templates.  
Prdx1 mRNA copy numbers were normalized to 18S mRNA copy numbers.  Prdx1 
mRNA levels (mean + SEM, n=3-15) are shown in bar graphs as % of static control.       




LS does not affect the mRNA stability of Prdx1. 
To verify that increased Prdx1 levels were due to active transcription, as opposed to 
mRNA stabilization, we evaluated the degradation rate of Prdx1 mRNA following in vitro 
shear stress.  In these experiments, BAEC were conditioned for 1 day with static culture, 
LS, or OS.  Transcription was then halted using the RNA polymerase II inhibitor DRB.  
mRNA levels were examined at time points between 0 and 12 hours following DRB 
treatment using quantitative, real time PCR.  Under static culture, Prdx1 mRNA levels 
fell to roughly 60% after 8 hours (Figure 4.2).  Interestingly, conditioning with neither LS, 
nor OS, affected this rate of mRNA degradation.  These results suggested that LS 
promotes production of the Prdx1 transcript, rather than protection of mRNA by 
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Figure 4.2  Prdx1 mRNA stability is not affected by shear stress.  Confluent BAEC 
were exposed to LS, OS or static conditions for 24h. Following shear stress, cells were 
treated with the RNA polymerase II inhibitor DRB (10µM) to stop transcription.  Total 
RNA was collected and purified cDNA was amplified via real-time, quantitative PCR as 
in Figure 4.1.  Prdx1 mRNA copy numbers were normalized to 18S mRNA copy 
numbers.  Prdx1 mRNA levels (mean + SEM, n=3-15) are shown in line graphs as % of 
time 0 hour for each group.    
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Bovine Prdx1 promoter is functional in BAEC. 
Thus far, we demonstrated that Prdx1 mRNA is upregulated in response to LS, but that 
this increase is not a product of mRNA stabilization.  Together, these results suggested 
that the Prdx1 expression mediated by shear stress is controlled at that transcriptional 
level.  To further investigate this hypothesis, the 5’ 1.4-kb region upstream of the bovine 
Prdx1 gene was cloned into either luciferase or CAT reporter constructs.  In validation 
studies, Prdx1 promoter-luciferase vector was transfected into BAEC, and luciferase 
activities were assessed following 6 hours of ST, LS, or OS.  Cells containing Prdx1 
promoter possessed significantly more luciferase activity then those with empty vector 
controls.  In addition, LS appeared to decrease activity in promoter groups, inconsistent 
with our previous findings (Figure 4.3).  However, this phenomenon occurred in control 
groups as well, and it has been widely reported that nitric oxide (NO) inhibits luciferase 
activity by decreasing luciferase mRNA stability24.  LS is a potent stimulator of NO 
suggesting that atheroprotective shear itself reduces luciferase activity, independent of 
promoter activation25.  Taken together, these data indicated that our promoter construct 








































Figure 4.3  Prdx1 promoter is functional in BAEC.  BAEC were transfected with either 
control pGL3 or Prdx1 promoter-pGL3 for 48 hours and then exposed to ST, LS, or OS 
for 6 hours.  Luciferase activity was measured, normalized to β-galactosidase internal 
control, and is represented in bar graphs as % of static control transfected with Prdx1 
promoter. 
 
The bovine Prdx1 promoter region contains a Nrf2 binding site. 
Due to the limited information on transcriptional regulation of bovine Prdx1, we also 
carried out computer-based sequence analysis to identify potential transcription factors 
in the promoter region of this gene.  Approximately 2 kb of genomic sequence, upstream 
of bovine Prdx1, were retrieved in FASTA format from the UCSC Genome Browser 
(http://genome.ucsc.edu)26, 27.  This sequence was analyzed using TFSEARCH (Version 
1.3) software for highly correlated sequence fragments in the TFMATRIX transcription 
factor binding site profile database (http://www.cbrc.jp/research/db/TFSEARCH.html)28, 29. 
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Employing a 95 point scoring threshold for vertebrate matrices, we discovered a single 
NF-E2-related factor 2 binding site located 160bp upstream of the transcription start site 
(Figure 4.4)30.  Based on these findings and previous studies of the ARE binding site, we 




Nrf2 Binding Site Prdx1 Gene
11   1      4      0      4      Y
10 8      1      0      0     A
09 0      8      0      1      C
08  0      0      1      8      T
07 0      3      6      0      S
06 9      0      0      0     A
05 0      0      9      0      G
04 0      0      0      9     T
03 1      8      0      0      C
02 2      0      7      0      G
01 2      2      0      5      T
P0      A      C      G      T
Consensus Sequence
 
Figure 4.4  The promoter region of bovine Prdx1 gene contains a Nrf2 binding site. 
On the left, the DNA consensus sequence for the Nrf2 transcription factor is shown30.  
This binding site is found 160bp upstream of the bovine Prdx1 gene.  
 
Nrf2 induces PRX 1 expression under static culture conditions. 
Our work has shown that LS, but not OS or ST, upregulates both Prdx1 gene and its 
product PRX 1 protein15.  To assess Nrf2’s capability to stimulate this event, we first 
attempted to induce PRX 1 production during static culture via exogenous Nrf2 protein 
expression.  In these studies, static BAEC were infected with either GFP adenovirus as 
a control or wild type human Nrf2 (GFP-tagged) adenovirus to overexpress Nrf2 protein.  
Immunofluorescence imaging of GFP was used to examine infection efficiency, and 
Western blot with Nrf2- and PRX 1-specific antibodies revealed adenovirus effectiveness 
and PRX 1 protein expression.  Compared to Ad-GFP (20 MOI), Ad-wt hNrf2 increased 
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both Nrf2 and PRX 1 in a dose-dependent manner in endothelial cells (Figure 4.5).  This 
data indicated that the transcription factor Nrf2 is able to promote PRX 1 protein 
expression under basal conditions and may contribute to shear stress-dependent 
transcription of Prdx1.  However, further work was necessary to establish whether Nrf2 











Figure 4.5.  Nrf2 stimulated PRX 1 expression in static cultured cells.  BAEC were 
infected with either GFP or hNrf2 Adenovirus (Ad) at indicated concentrations for 48 
hours.  Intracellular protein was analyzed by Western blot using antibodies specific to 
Nrf2 and PRX 1.  
 
Nrf2 contributes in part to LS-induced Prdx1 expression. 
The depletion of Nrf2 from cellular systems provides a useful tool to study its functional 
role in endothelial cells.  In the following experiments, specific siRNA was used to 
knockdown Nrf2 in order to investigate Prdx1 expression in BAEC.  Quantitative, real-
time PCR with Nrf2- and Prdx1-specific primers was used to determine the efficacy of 
this siRNA, as well as the effect on basal Prdx1 levels.  Compared to non-silencing 
siRNA and Alexa Fluor 546-labeled non-silencing siRNA (50 nM each), 48 hour-
treatment of BAEC with Nrf2 siRNA dramatically reduced (by 70% of non-silencing 
control) expression of Nrf2 mRNA, at a concentration as low as 20nM (Figure 4.6A).  In 
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addition, Nrf2 siRNA also decreased Prdx1 mRNA by 40-50% of controls at all doses 
(Figure 4.6B).  In conjunction with data from adenovirus experiments, these findings 
provided further support for Nrf2’s role in PRX 1 regulation and suggested that Nrf2 may 
be important to Prdx1 expression even under static conditions.  Furthermore, we were 
able to perform subsequent studies using Nrf2 siRNA at 20nM concentration with 
confidence. 
 
To determine whether Nrf2 is responsible for the LS-dependent increase in Prdx1 levels 
in BAEC, we knocked down Nrf2 using Nrf2 siRNA as indicated above (Figure 4.6A).  
Nrf2 depletion significantly decreased Prdx1 mRNA in both LS- and OS-treated cells 
(Figure 4.7A).  However, after 72 hours of treatment (48 hours transfection, followed by 
24 hours of shear stress), Nrf2 levels were reduced only 40-50% (Figure 4.7B).  Despite 
this reduced knockdown of Nrf2, the results of these studies indicated that Nrf2 



































































































































Figure 4.6   Nrf2 siRNA inhibits Nrf2 mRNA and reduces expression of Prdx1 gene 
in static cultured cells.  BAEC were transfected with either non-silencing (NS) , Alexa-
labeled non-silencing (A) or Nrf2 siRNA at indicated concentrations for 48 hours.  Total 
RNA was collected and reverse-transcribed to synthesize first-strand cDNA, which was 
amplified via real-time, quantitative PCR.  mRNA copy numbers were determined based 
on standard curves generated with bovine Prdx1, bovine Nrf2 and 18S templates.  Nrf2 
and Prdx1 mRNA copy numbers were normalized to 18S mRNA copy numbers.  Nrf2 
and Prdx1 mRNA levels (mean + SEM, n=12) are shown in bar graphs as % of non-
silencing siRNA-treated control.  * p<0.05 designate significance between indicated 































































































Figure 4.7  Nrf2 knockdown reduces Prdx1 expression in response to LS.  BAEC 
were transfected with either non-silencing (NS) or Nrf2 siRNA (20nM) for 48 hours and 
then exposed to ST, LS, or OS for 24 hours.  Total RNA was collected and cDNA was 
amplified via real-time, quantitative PCR as in Figure 4.5.  Nrf2 and Prdx1 mRNA copy 
numbers were normalized to 18S mRNA copy numbers.  Nrf2 and Prdx1 mRNA levels 
(mean + SEM, n=12) are shown in bar graphs as % of non-silencing siRNA-treated static 






Through gene expression and siRNA depletion studies, we have discovered that: (1) LS 
upregulates Prdx1 gene in a time-dependent manner compared to both OS and static 
culture conditions, but (2) this increase in expression is not due to stabilization of Prdx1 
mRNA; (3) The bovine Prdx1 promoter region contains a Nrf2 binding site, and (4) Nrf2 
overexpression promotes basal PRX 1 protein production, while (5) Nrf2 knockdown 
reduces Prdx1 mRNA following exposure to LS.  Collectively, these results suggest that 
laminar shear stress affects PRX 1 by inducing the Prdx1 gene, in part via the 
transcription factor Nrf2.   
 
Recent findings by our group showed that intracellular PRX 1 protein is upregulated by 
chronic laminar shear stress in BAEC and plays a crucial part in shear stress-dependent 
hydrogen peroxide diminution15.  Through the current study, we sought to investigate the 
pathway by which LS promotes PRX 1 expression.  The observed rise in protein 
generation could occur via several mechanisms, including increased transcription, 
mRNA stabilization, and augmented translation.  As illustrated in Figure 4.1, the 
elevation of Prdx1 mRNA levels suggested that PRX 1 expression is transcriptionally 
regulated.  The time-dependent nature of this response and the lack of mRNA 
stabilization by shear stress indicated that mRNA is being produced in response to LS 
over the course of hours (Figure 4.2).  
 
Several reports have demonstrated that other cytoprotective genes are also induced by 
laminar shear stress in endothelial cells.  Chen et al. discovered NQO1, HO-1, 
microsomal epoxide hydrolase, glutathione S-transferase (GST), ferritin, and γ-
glutamylcysteine synthase as targets of laminar flow in human aortic endothelial cells 
and human microvascular endothelial cells19.  Work by Dai et al. also identified NQO1, 
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HO-1, and ferritin, as well as GSR, GCLM, and TXNRD1, as genes promoted by 
atheroprotective, but not atheroprone, flow in human umbilical vein endothelial cells21.  
The common thread amongst these phase II detoxification and antioxidant genes is the 
presence of an antioxidant response element (ARE) in their 5’ flanking regions31-33.  This 
ARE is activated by cellular exposure to insults that induce oxidative stress, including 
hydrogen peroxide, ionizing radiation, and a variety of chemical compounds34.  Recently, 
it has also been shown to respond to chronic, steady laminar shear stress through its 
transcription factor Nrf219, 21, 35. 
 
Although the mechanism of shear stress-mediated Nrf2 induction remains controversial, 
the conserved nature of the ARE/Nrf2 sequence in cytoprotective, mechanosensitive 
genes suggested that it may also be important to the regulation of PRX 1 (Figure B.1)21, 
35.  Interestingly, analysis of the bovine Prdx1 promoter revealed a Nrf2 binding region 
160bp upstream of the transcription start site.  Further investigation also found that 
overexpression of Nrf2 stimulated the production of intracellular PRX 1 protein, while 
Nrf2 depletion significantly reduced transcription of Prdx1 mRNA in response to LS, as 
well as static conditions and OS.  Together these results suggested that Nrf2 is an 
important contributor to both basal and shear stress-mediate PRX 1 production.   
 
In support of our findings, studies in other cell types have also linked the ARE/Nrf2 
system to PRX 1 expression.  Ishii et al. showed PRX 1 to be induced by Nrf2 via 
oxidative stress.  In peritoneal macrophages from Nrf2-deficient mice, PRX 1 generation 
was blunted in response to stress agents such as paraquat and CdCl236.  Additionally,  
other work found nuclear translocation of Nrf2 promoted human Prdx1 gene expression 




However, in the current study, Nrf2 knockdown did not fully abolish the LS-mediated 
upregulation of Prdx1 mRNA (Figure 4.7A).  These findings may be a product of reduced 
Nrf2 siRNA efficacy (less than 50% reduction at 3 days), or these data may imply that 
Nrf2 is not the only factor relevant to Prdx1 transcription.  Tumor promoters such as 12-
O-tetradecanoylphorbol-13-acetate (TPA) have been found to activate transcription 
factor AP-1 sites in the rat prx1 promoter of macrophages and monocytes37.  Our 
analysis of genomic sequence upstream of bovine Prdx1 also identified several AP-1 
binding sequences in its promoter region.  Consistent with the action of PRX 1 in BAEC,     
AP-1-regulated genes allow cells to respond oxidative stress38.  Additional studies with 
the bovine Prdx1 promoter-CAT construct will allow for further investigation of Nrf2, AP-1, 
and other transcription factor binding sites.  In addition, recent work by Diet et al. 
showed that PRX 1 and 6 are controlled by endogenously-produced NO in 
macrophages39.  It is well established that endothelial cells generate NO in response to 
LS25, 40.  This may represent a supplementary pathway for shear stress-dependent PRX 
1 expression in BAEC.   
 
In summary, we have shown that laminar shear stress promotes the expression of 
bovine Prdx1, and that transcription factor Nrf2 may contribute to this important pathway.  
Furthermore, this discovery of Prdx1 gene as a mechanosensitive transcript may 
contribute critical insights into endothelial cell biology and therapeutics for vascular 
diseases.   
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Summary and Conclusions 
In the United States alone, cardiovascular disease kills nearly 2600 people each day; its 
primary cause, atherosclerosis, affects millions of Americans each year1.  Despite the 
localized nature of plaque formation in the arterial tree, preventative pharmaceutical 
treatments remain limited to drugs targeting systemic risk factors.  In order to address 
the hemodynamic components of atherosclerosis development, recent work has focused 
on the mechanosensitive endothelium to establish new pathological mechanisms.  
Understanding how unidirectional, laminar blood flow protects vessels from 
atherogenesis, while disturbed, oscillatory blood flow promotes it, will provide enormous 
insight into direct therapeutic approaches for cardiovascular disease intervention. 
 
The overall objective of this dissertation was to study the effects of atherogenic and 
atheroprotective fluid flow profiles on the mammalian antioxidants peroxiredoxins, and to 
identify mechanosensitive family members playing a role in redox regulation.  By 
understanding how peroxiredoxins are regulated and what roles they play 
physiologically, we will have better insight into endothelial cell (EC) biology and redox-
sensitive mechanisms of vascular diseases.  The central hypothesis of this project was 
that unidirectional laminar shear stress (LS), compared to disturbed oscillatory shear 
stress (OS), promotes increased expression of peroxiredoxins (PRX) via transcriptional 
regulation, which in turn influences the balance of reactive oxygen species in endothelial 
cells.  This hypothesis was tested according to three specific aims using cellular, 
molecular, and biochemical studies of bovine aortic endothelial cells:       
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• Specific Aim 1: Investigate shear stress-dependent expression and 
subcellular localization of peroxiredoxin family members in aortic 
endothelial cells. 
 
• Specific Aim 2: Identify the role of PRX 1 in shear stress-dependent 
reactive oxygen species regulation. 
 
• Specific Aim 3: Investigate the mechanism of shear stress-dependent PRX 
1 expression in aortic endothelial cells. 
 
To achieve these specific aims, we first explored the effects of shear stress on 
expression of mammalian peroxiredoxin family members.  Using an in vitro model, the 
cone-and-plate viscometer, we applied atheroprotective, high, unidirectional laminar 
shear stress or atherogenic, low, oscillatory shear stress to endothelial cells in culture.  
Previous studies established that reactive oxygen species (ROS) play a critical role in 
atheroma formation2-5.  Peroxiredoxins have the ability to regulate ROS by reducing 
peroxides and eliminating peroxynitrite, but are understudied endothelial cell biology6, 7.  
Here, we were able to identify all six PRX family members in bovine aortic endothelial 
cells (BAEC).  Furthermore, through this work, we revealed for the first time that PRX 
are regulated by shear stress in endothelial cells.  When compared to OS and static 
culture, exposure to chronic LS upregulated PRX 1 levels intracellularly.  LS also 
increased expression of PRX 5 relative to static controls, but not OS.  Consistent with 
reports in other cell types, PRX exhibited broad subcellular localization in BAEC, with 
distribution in the cytoplasm, Golgi, mitochondria, and intermediate filaments8, 9.  
However, these localization patterns did not appear to change in response to shear 
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stress.  Taken together, our results suggest that distribution of PRX in specific 
subcellular environments may provide protection against local ROS production and 
facilitate ROS-mediated signal transduction.  Simultaneously, widespread allocation of 
PRX might also be important for comprehensive management of the overall oxidative 
state of cells.  Moreover, upregulation of PRX 1 by LS may act to reduce ROS levels in 
EC and prevent atherogenic oxidative stress.  
 
To establish the functional importance of PRX 1 in shear stress-dependent redox 
balance, we next examined the role of PRX 1 in LS-mediated hydrogen peroxide 
regulation.  Endothelial cells exposed to OS experience oxidative stress as a signature 
of atherosclerosis.  Conversely, chronic LS reduces ROS levels2, 4, 5.  Here, we used 
Amplex Red assay as an independent method to measure ROS levels in BAEC.  
Consistent with previous reports, OS increased and LS decreased catalase-inhibitable 
hydrogen peroxide.  Subsequently, we investigated whether PRX 1 was responsible for 
the decreased H2O2 levels in endothelial cells exposed to LS.  Specific siRNAs were 
used to knockdown either PRX 1 or PRX 5 protein levels.  Using isoform-specific PRX 
antibodies, we found that these siRNAs had no significant effect on other PRX, 
indicating that they exclusively targeted PRX 1 or 5, respectively, amongst all PRX 
family members.  Depletion of PRX 1 using siRNA resulted in significantly higher ROS 
levels in BAEC exposed to LS, OS, and static conditions, while PRX 5 depletion did not.  
Altogether, these results indicate that chronic exposure to LS upregulates PRX 1 
expression in order to keep ROS levels low in endothelial cells.  
 
To identify the pathway by which atheroprotective laminar shear stress stimulates PRX 1 
protein production, we undertook additional gene expression and siRNA depletion 
studies.  Several reports have demonstrated that antioxidant genes are induced by 
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laminar shear stress in endothelial cells10, 11.  In line with this, we discovered that LS 
upregulates Prdx1 gene in a time-dependent manner compared to OS or static culture.  
However, this increase in expression was not due to shear stress-dependent 
stabilization of Prdx1 mRNA.  These findings lead us to believe that Prdx1 was likely 
regulated at the transcriptional level.  In addition, the antioxidant response element 
(ARE) has been shown to be conserved amongst several antioxidant genes, and studies 
showed it responds to chronic, steady laminar shear stress through its transcription 
factor Nrf210-14.  Our analysis of the bovine Prdx1 promoter revealed a Nrf2 binding site 
160bp upstream of the gene.  Furthermore, Nrf2 overexpression promoted basal PRX 1 
protein production, while Nrf2 depletion reduced Prdx1 mRNA following exposure to LS.  
Collectively, our work illustrates that laminar shear stress affects PRX 1 by inducing the 
Prdx1 gene, in part via the transcription factor Nrf2.  
 
By addressing the three specific aims proposed, this project has developed a 
comprehensive register of shear stress-dependent peroxiredoxin behavior and 
discovered a novel mechanosensitive antioxidant that plays an important functional role 
in redox regulation of endothelial cell biology.  This dissertation illustrates how 
physiologically relevant fluid flow affects reactive oxygen species, through the unique 
expression of antioxidants, in particular Peroxiredoxin 1 (Figure 5.1).  Identifying factors 
that play an important role in shear stress-dependent oxidative stress could help provide 
localized therapies at the site of endothelial cell dysfunction.  Our findings are relevant to 
the inflammatory disease atherosclerosis, a major cause of cardiovascular disease.  By 
understanding how PRX1 is regulated and what role it plays in physiology, we can better 
understand vascular diseases and develop effective preventative therapeutic 
approaches.  
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There are several limitations to the work performed in this project including, but not 
restricted to, the following points: 
1. Use of cultured cells 
2. Use of bovine aortic endothelial cells 
3. Use of simulated blood flow conditions 
4. Assessment of ROS limited to global levels 
5. Investigation of one potential transcription factor 
6. In vivo studies limited to future work 
 
In this dissertation, studies were performed solely with an in vitro model.  To simplify the 
experimental layout, endothelial cells alone were examined.  Unfortunately, cells 
cultured in a dish likely behave differently from those in body.  In the vasculature, 
endothelial cells are in close proximity to several other cells types, including smooth 
muscle cells, fibroblasts, and leukocytes.  Studies have previously shown that shear 
stress promotes the release of factors from the endothelium that directly affects smooth 
muscle cells and leukocytes15.  Thus, it probable that communication with other cell 
types equally affects endothelial cell behavior16. 
 
Here, bovine aortic endothelial cells were chosen to represent the arterial endothelial 
cells exposed to physiologically significant flow patterns in vivo.  To directly relate our 
findings to human pathologies, it would be more appropriate to employ a human 
endothelial cell line.  Many groups have used human umbilical vein endothelial cells in 
studies similar to ours17.  However, endothelial cells in veins do not typically experience 
the shear stress profiles found in large arteries, and as a result, may be conditioned to 
respond differently.  Although human aortic endothelial cells are available, BAEC offer 
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considerable ease of culture and should experience somewhat similar fluid flow patterns 
in vivo. 
 
To evaluate shear stress-dependent endothelial cell behavior, we utilized a cone-and-
plate viscometer.  As previously described, this system provides a simplified, well-
defined simulation of hemodynamic environments.  In contrast, the fluid flow endothelial 
cells experience in vivo is much more complex.  This in vitro model fails to account for 
the pulsatility of blood flow generated by the heart, as well as normal pressure and cyclic 
stretch EC might perceive in an in vivo mechanical environment18.  Although many 
others have shown that in vitro shear systems convincingly recapitulate in vivo findings, 
it remains possible that some responses may be different19, 20. 
 
Beyond the in vitro aspect of this work, other limitations also constrained our findings.  In 
Chapter 3, we discovered that PRX family members were located throughout the cellular 
milieu of BAEC. This indicated they may provide protection against local sources of 
ROS.  In subsequent functional experiments, we were only able to assess the overall 
oxidative state of cells in response to PRX depletion.  Currently available techniques do 
not allow for examination of ROS at specific intracellular organelles, but such studies 
may be particularly informing with respect to the many PRX family members.  In 
addition, this project explored only a single possible transcription factor for the 
mechanosensitive Prdx1 gene.  As discussed in Chapter 4, several other candidates 
exist and should be addressed in further work.  Finally, this dissertation did not examine 
the in vivo implications of in vitro findings.  Future experiments should validate these 





The sheer number of peroxiredoxins, and their poor representation in the 
mechanobiology field, signifies many new opportunities for atherosclerosis research.  
The findings described in this dissertation have laid the groundwork for additional future 
studies of Peroxiredoxin 1 in endothelial cells exposed to shear stress.  Advancement of 
this work may focus on both in vitro and in vivo experimental approaches.  
 
Signaling pathways 
Our finding that laminar shear stress upregulates PRX 1 may be relevant to several 
signal transduction pathways.  Shear stress has been shown to influence a number of 
important signaling cascades in endothelial cells.  MAP kinases including ERK 1/2, JNK, 
and p38 are differentially affected by fluid flow profiles and affect downstream targets 
such as eNOS and Akt21, 22.  In addition, LS inhibits, while OS promotes, the 
inflammatory pathway of NF-κB.  Previous work has established that PRX 1 is an 
important regulator of p38 in macrophages exposed to oxidative stress23.  Similarly, PRX 
1 affects NF-κB, suppressing NF-κB transcriptional activity, JNK activity and apoptosis 
induced by TNF-α9, 24.  Experiments using PRX 1 siRNA would reveal if LS-dependent 
PRX 1 expression regulates any of these critical pathways in response to shear stress.  
 
In vitro physiological roles 
In Chapter 3, we showed that PRX 1 significantly affects the redox state of endothelial 
cells exposed to shear stress.  However, we did not explore the functional endpoint of 
this role.  Reactive oxygen species play an important part in many physiological 
functions relevant to atherosclerosis, including apoptosis and inflammation.   Both of 
these events are inhibited in endothelial cells exposed to atheroprotective laminar shear 
stress, and apoptosis has been linked to PRX 1 in cancer cells15, 25.  As such, further 
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work should focus on the shear stress-dependent role of PRX 1 in apoptosis and 
inflammation of endothelial cells.  Analysis of in vitro markers such as Annexin V and 
monocyte attachment, in conjunction with PRX 1 depletion, would provide valuable 
mechanistic insight into these cellular behaviors.     
 
Transcription factors 
Studies in Chapter 4 indicated that fluid flow regulates PRX 1 at the transcriptional level, 
and Nrf2 contributes in part to the mechanism.  Additionally, this work suggested that 
Nrf2 may not be the only factor promoting Prdx1 expression.  As described above, both 
NO and AP-1 elevate Prdx1 expression in monocytes and macrophages26, 27.  
Endothelial cells generate NO in response to atheroprotective shear stress16, 28.  
Valuable experiments might employ the nitric oxide donor diethylenetriamine NONOate 
(DETA-NO) to induce Prdx1 expression in static cells or those exposed to OS.  In 
contrast, the NO synthase inhibitor NG-nitro-L-arginine methyl ester (L-NAME) could be 
used to block LS-dependent transcription.  Furthermore, the transcription factor AP-1 is 
also shear stress responsive and has been implicated in cellular response to oxidative 
stress29, 30.  As previously mentioned, our analysis of genomic sequence upstream of 
Prdx1 identified several AP-1 binding sequences in its promoter region.  We have 
recently cloned the bovine Prdx1 promoter into both luciferase and chloramphenicol 
acetyltransferase (CAT) reporter vectors.  These constructs could be transfected into 
endothelial cells exposed to LS, OS or static culture.  Truncation and mutation studies 
may reveal the importance of many transcription factor binding sites, including AP-1.     
   
In vivo implications 
Ultimately, in vivo research must be performed to validate the in vitro findings of this 


























Figure 5.2  The mouse aortic arch is a model for both LS- and OS-like flow. 
Following isolation, the arch is embedded, frozen and sectioned as depicted on the right. 
This allows for examination of both the atheroresistant GC and atheroprone LC regions 
in the same cross-section.  Figure on left reprinted with permission31.  Copyright © 2007 













Figure 5.3  PRX 1 expression is elevated in the LS-like GC of the aortic arch.  
Frozen sections of aortic arches from wt C57BL6 mice were stained with PRX 1-specific 
antibodies and Alexa Fluor 568-conjugated secondary (red). Nuclei were counter-stained 
with Hoechst (blue) and elastic lamina autofluorescence is green. L = vessel lumen.  
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regulated by shear stress in the aorta.  As determined by computational fluid dynamics, 
the mouse aortic arch serves as an excellent model for both unidirectional laminar shear 
stress and disturbed, oscillatory shear stress (Figure 5.2)31.  The greater curvature (GC) 
experiences flow much like in vitro LS, while the lesser curvature (LC) is exposed to OS-
like conditions.  Here, frozen cross-sections of the arch were stained with PRX 1-specific 
antibodies.  Immunofluorescent images revealed elevated PRX 1 expression in the GC 
region, consistent with our in vitro findings in Chapter 3 (Figure 5.3).  En face 
immunostaining will be necessary to confirm these results and verify that PRX 1 staining 
is endothelial cell specific. 
 
Further studies in animal models will be required to establish the physiological relevance 
of PRX 1 in atherosclerosis progression.  To determine whether endothelial PRX 1 
expression correlated with atherosclerotic lesion development, we stained human 
coronary arteries with various stages of disease.  Serial sections of human coronary 
arteries were stained with both PRX 1- and PECAM-1-specifc antibodies.  As illustrated 
in Figure 5.4, PECAM-1 was used to verify an intact endothelial cell layer in all sections.   
In low-magnification images (Figure 5.5), PRX 1 was easily detected in the endothelium 
and medial layer regardless of disease stage.  However, expression in the intimal 
smooth muscle layer tended to decrease as disease progressed.  Examination of high-
magnification images (Figure 5.6) further supported this phenomenon.  Although these 
findings do not implicate endothelial-derived PRX 1 in plaque development, they are 
consistent with previous studies of PRX.  Work by Choi et al. found that PRX 2 prevents 
PDGF-dependent smooth muscle cell proliferation and migration in neointimal 
thickening32.  Additional assessment of PRX 1 in this model may reveal a similar function 
role in smooth muscle cells.     
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Finally, PRX 1 knockout mice also are available, and erythrocytes and embryonic 
fibroblasts from these animals contain higher levels of ROS than their wild type 
counterparts33.  Crossing these mice with ApoE-/- mice, and feeding them high fat diet, 
will generate a model that is both hyperlipidemic and oxidatively stressed.  
Atherosclerosis development could be evaluated in these animals using traditional 
assessment of plaque formation via en face Oil Red O staining, as well as in a shear 
stress models such as partial carotid ligation or aortic coarctation.        
 
In summary, the future directions of this project should examine the in vivo 
consequences of shear stress and peroxiredoxins in atherosclerosis.  By understanding 
the mechanisms behind plaque formation, important therapies can be developed.  
Cardiovascular disease is the primary cause of death in the United States.  Clarifying the 
role of antioxidants such as PRX 1 in its progression could provide insight into direct 















Figure 5.4  PECAM-1 verifies an intact endothelium in human coronary arteries. Frozen sections from human coronary arteries 
with various stages of disease were stained with either PRX 1- or PECAM-1- specific antibodies and Alexa Fluor 568-conjugated 
secondary (red). Nuclei were counter-stained with Hoechst dye (blue) and elastic lamina autofluorescence is green. 
 
Red = PECAM-1 
Red = PRX 1 
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Figure 5.5  PRX 1 expression did not change in the endothelium as disease progressed.  Frozen sections from human 
coronary arteries were stained for PRX 1 (red) as described in Figure 5.5.  Nuclei were counter-stained with Hoechst dye (blue) and 
elastic lamina autofluorescence is green. Hatched boxes are shown at higher magnification in Figure 5.6. 
Type I Type II-III Type III-IV Type IV-V 
Red = PRX I, Blue = Nuclei, Green = Elastic Lamina
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Figure 5.6  PRX 1 expression decreased in the intimal smooth muscle with increasing disease progression. Frozen sections 
from human coronary arteries were stained as described in Figure 5.6.  Higher magnification images are shown here according to 
American Heart Association classification. L = vessel lumen. 
Type I Type II-III 





Red = PRX I, Blue = Nuclei, Green = Elastic Lamina
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Analysis of Secreted PRX in Response to Shear Stress 
In Chapter 3, we investigated the intracellular expression of all six peroxiredoxin family 
members.  Our results showed that PRX 1 was induced by chronic laminar shear stress 
(LS), compared to oscillatory shear stress (OS) and static (ST) control.  Further studies 
were conducted to assess whether extracellular PRX were also regulated by shear 
stress.  As previously described, bovine aortic endothelial cells (BAEC) were exposed to 
static culture, LS at 15 dynes/cm2, or OS at ±5 dynes/cm2 for 24 hours.  Following 
experimental treatment, conditioned medium was collected from culture dishes.  To 
prepare secreted proteins, this media was centrifuged at 1,000 x g for 10 minutes to 
remove cell debris, and the supernatant was concentrated via spin column (Vivaspin) at 
40C.  The protein content of each sample was determined by Bio-Rad DC assay, and 
immunoblots were performed as before for PRX 1, 2, 3, 4, 5, and 6. 
 
We were able to detect PRX 2, 4 and 6, but not PRX 1, 3 or 5, in concentrated media 
taken from BAEC.  Levels of PRX 2 and 6 were significantly elevated in response to LS, 
while PRX 4 was unaffected by shear (Figure A.1).  Previous studies have shown that 
PRX 4 contains a secretion signal peptide at its amino terminus and is secreted 
extracellularly1.  In contrast, PRX 2 and 6 are recognized as cytosolic proteins.  The 
presence of PRX 2, 4, and 6 in conditioned media taken from static control cells 
supported the concept that these PRX are secreted from BAEC under basal conditions.  
In addition, the absence of PRX 1, 3, and 5 implied that not all cytosolic proteins are 
released.  However, the suggestion that shear stress promotes increased secretion, 
independent of cellular damage, required further confirmation.   
 
To address this concern, we probed conditioned media for the non-exporting proteins, 
actin and lactate dehydrogenase (LDH).  Both actin and LDH were increased by LS, 
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despite modification to our cone-and-plate shear stress apparatus and the well-known 
protective effect of laminar shear stress on endothelial cells.  As such, we were unable 
to exclude the possibility that PRX found in the conditioned media was a result of cell 
membrane damage during shear stress exposure (Figure A.1).  However, it is most likely 
that a few senescent or weak endothelial cells are detached from the substrate by shear 
stress, and subsequently release actin and LDH into the media.  
 






ST     LS    OS
 
Figure A.1  PRX 2, 4, and 6 are present in conditioned media taken from BAEC. 
Confluent BAEC were exposed to LS, OS or static conditions for 1 day, and the 
conditioned media was obtained.  Equal aliquots of media (20 µg of protein each) were 
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Analysis of Nrf2 mRNA in Response to Shear Stress 
In Chapter 4, we investigated the antioxidant response element (ARE) as a potential 
mediator of laminar shear (LS)-induced Prdx1 gene expression.  Previous studies have 
found that the ARE is conserved amongst several mechanosensitive, cytoprotective 
genes and responds to chronic laminar shear stress through the transcription factor NF-
E2-related factor 2 (Nrf2)1.  However, the exact mechanism by which Nrf2 responds to 
shear stress remains controversial.   
 
Transcription factor Nrf2, a basic leucine zipper protein (bZIP), activates the ARE and its 
downstream genes by binding to ARE consensus sequence.  Under homeostatic 
conditions, the cytoskeleton binding protein Kelch-like ECH-associated protein 1 (Keap1) 
binds Nrf2 in the cytoplasm and targets it for degradation via the ubiquitin-proteasome 
system.   However, when cells are exposed to stress, Nrf2 is released and travels to the 
nucleus, where it forms a heterodimer with another bZIP, Maf, and binds to the ARE1-5.  
In human aortic endothelial cells (HAEC) and human microvascular endothelial cells, 
Chen et al. first showed that anti-sense Nrf2, dominant negative Nrf2, and 
overexpression of Keap1 could all block laminar flow-induced activation of ARE-
mediated genes1.  Later work in both HAEC and human umbilical vein endothelial cells 
(HUVEC) corroborated these findings using Nrf2-specific siRNA4, 6, 7.  However, several 
discrepancies exist in these recent studies concerning the mechanism of regulation of 
Nrf2 by shear.  
 
In 2005, Hosoya et al. reported that both LS and OS induce nuclear accumulation of 
Nrf2 in HAEC.  Nonetheless, OS prevents Nrf2 binding to the ARE, and subsequent 
gene transcription, through an unknown nuclear factor4.  On the other hand, Dai et al. 
showed in HUVEC that “atheroprotective” shear stress, compared to “atherprone” shear 
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stress, increased nuclear accumulation of Nrf2, but did not affect cytoplasmic protein 
levels.  Using en face immunohistochemical staining, they found a similar Nrf2 
expression pattern in atherosclerosis-resistant regions of the mouse aorta6.  Finally, 
Warabi et al. established that intracellular protein levels of Nrf2 were markedly increased 
in HUVEC, although the mRNA levels of Nrf2 were unchanged.  They demonstrated that 
shear stress stabilizes Nrf2 protein via an ROS-dependent pathway7.     
 
To examine how LS might promote Prdx1 expression through Nrf2 in bovine aortic 
endothelial cells (BAEC), we assessed Nrf2 gene expression in response to shear stress.  
Total RNA was collected from BAEC following static culture (ST), or 2, 4, 8 or 24 hours 
of LS (15dynes/cm2) or oscillatory shear stress (OS, ±5dynes/cm2).  Quantitative, real 
time PCR was used to determine Nrf2 mRNA copy number relative to the internal control 
18S.  As illustrated in Figure B.1, we found that Nrf2 expression increased in response 
to laminar shear stress after 8 hours and by 24 hours was significantly different from 
both ST and OS.  Though this temporal pattern did not exactly match the regulation of 
Prdx1 by LS, it did suggest that chronic LS regulates Nrf2 gene in BAEC.  As implied by 
work in other cell types, gene regulation of Nrf2 may not be the only mechanism for 
regulation.  It is possible that LS stabilizes Nrf2 protein or affects the nuclear 
translocation of Nrf2.  However, in conjunction with previous findings, our studies 
suggest that Nrf2 may be uniquely regulated by LS in endothelial cells of different origin 
and species.  Similarly, the magnitude of shear stress and the in vitro model system 
































































Figure B.1  Nrf2 mRNA is upregulated by LS compared to OS.  Confluent BAEC 
were exposed to LS, OS or static conditions for 2, 4, 8, or 24h. Total RNA was collected 
and reverse-transcribed to synthesize first-strand cDNA, which was amplified via real-
time, quantitative PCR.  mRNA copy numbers were determined based on standard 
curves generated with bovine Nrf2 and 18S templates.  Nrf2 mRNA copy numbers were 
normalized to 18S mRNA copy numbers.  Nrf2 mRNA levels (mean + SEM, n=3-15) are 
shown in bar graphs as % of static control. * p<0.05 designate significance between 
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